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Abstract
The basis of public health surveillance is the reporting of diseases and conditions to the
health department by clinicians and laboratories. In the United States, over eighty diseases and
conditions of national importance (e.g., tuberculosis, syphilis, and cancer) are included on the list
of Nationally Notifiable Conditions (NNC) for submission to the Centers for Disease Control
and Prevention (CDC) by the states. The legal basis for disease reporting is found at the state
level, where inconsistent laws may differ in terms of which conditions are reportable and their
reporting process. The process by which states require the reporting of NNCs has not been
thoroughly described, and the potential bias introduced by different reporting requirements has
not been evaluated.
State reportable disease lists were collected from state health department websites, state
laws, and published CDC annual summaries. A descriptive, cross-sectional analysis of the
reporting requirements of all 50 states, Washington D.C. and New York City was conducted.
Factors associated with the states (e.g., population, public health funding) were evaluated to
determine if any were associated with having large number of NNCs on the state’s reportable
lists. Factors associated with the conditions (e.g. being vaccine preventable or a bioterrorism
agent) were evaluated to determine if any were associated with the inclusion on state reporting
lists. Additionally, pediatric influenza mortality, lead poisoning, tuberculosis and Shiga toxinproducing Escherichia coli infections were selected for an in-depth analysis of state reporting
requirements.
States required 76% to 100% (mean 90%) of NNCs to be reported; only Louisiana
required the reporting of all NNCs. No factors associated with the conditions were identified as
having a significant association with being included on state reportable lists; only 43% of NNCs
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were reportable in all states. States used 28 different reporting timeframes and required reporting
by 72 different types of reporters. Having a larger state population was associated with requiring
a greater number of NNCs to be reported, but no linear relationship was identified. Detailed
analysis of the selected conditions found that states did not follow national recommendations
when setting state reporting criteria; the inclusion of a new condition on the NNC list is a
reflection of reporting practices already established in states, and as such, is not an effective tool
to change state reporting practices.
NNC data is frequently used in policy making, funding, and program evaluation, and bias
introduced by different state reporting practices may make data collected unreliable for these
purposes. This study proposes a method for the standardization of reporting practices across
states, allowing for the standardize collection and interpretation of NNC data.
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Chapter 1 – Introduction
Introduction
In December of 2014, the Centers for Disease Control and Prevention (CDC) released the
2013 annual summary data for sexually transmitted infections. The news media focused on
interstate differences in this report, leading stories with “Obviously you shouldn't have
unprotected casual sex, but it you do, you might want to avoid the Deep South” (Moffitt, 2015).
The report states in the appendix that “…differences in policies and systems for collecting
surveillance data may exist. Thus, comparisons of case numbers and rates between jurisdictions
should be interpreted with caution.” (Centers for Disease Control and Prevention, 2014f, p. 128)
However, this admonition was obviously ignored by the media, where national data are typically
treated as if bias during the data collection process does not exist or does not affect the collected
data.
Journalists are not the only people who fall into the trap of ignoring the limitations of
data. Scientific researchers using the Nationally Notifiable Diseases Surveillance System
(NNDSS) often fail to consider the role of interstate differences in the disease reporting process,
the effects of which may be magnified when evaluating small populations or rare diseases. For
example, in an evaluation of racial and ethnic differences in disease reporting of 26 conditions
from 2007-2011, Adekoya, Truman and Landen (2015) found that fewer than 1% of case reports
made in NNDSS were for American Indians/Alaska Natives, with five of these conditions having
an average of fewer than ten reports per year. Underlying legal differences in disease reporting
laws were not listed as a limitation of the study, despite the possible importance of reporting
differences leading to the over- or under- reporting of a single case being potentially statistically
significant.
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The legal basis for the NNDSS, an integrated system of state-based surveillance systems
that provides a national picture of disease in the United States, is rooted in a variety of state laws
and codes. Issues of bias related to the underlying legal process of collecting data are rarely
understood, much less considered, when the data are ultimately utilized as part of policy or
research decisions.
In general, the process by which conditions are added to the Nationally Notifiable
Conditions (NNC) list and placed under national surveillance within the NNDSS, a core piece of
the data collection system for basic public health surveillance in the United States, is not well
described, and the bias introduced into the system by having different reporting criteria in each
state has not been thoroughly described or evaluated.
Statement of the Problem
A gap in the literature was identified concerning the process of annually updating the list
of nationally notifiable conditions. When a disease is added to the list, it is officially
recommended that “all States and Territories enact laws (statue or rule/regulation as appropriate)
to make this disease or condition reportable in their jurisdiction.” (Council of State and
Territorial Epidemiologists, 2015, p. 2) Additionally, the formal recommendation to add a
condition to the nationally notifiable conditions list (as well as subsequent updates) contains
guidance on how public health jurisdictions should implement the disease reporting requirements
in terms of 1) who should be required to make the report and 2) the clinical criteria that should
instantiate a report and 3) laboratory criteria that should instantiate a report.
To date, there has been no systematic evaluation of how states implement reporting
requirements within their disease reporting legal framework. Additionally, there has been no
evaluation of the states’ implementation of specific reporting criteria, and it is currently unknown
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if what is reportable in the states matches the agreed-upon national recommendations. As a
result, it is not possible to compare data across states with any level of confidence.
Background
The World Health Organization (2015) defines public health surveillance as the
“continuous, systematic collection, analysis and interpretation of health-related data needed for
the planning, implementation, and evaluation of public health practice” (para. 1), which
recognizes the sustained effort required to conduct surveillance, its scientific basis, and its
applied nature. Sullivan et. al (2010) describe public health surveillance more simply as
“information for action.” (p. 88). In short, public health surveillance provides the data needed to
drive public health action and to evaluate the results of those actions.
In the United States, the foundation of national-level disease surveillance is the
Nationally Notifiable Diseases Surveillance System (NNDSS). The NNDSS is a collaborative
system across all government health departments (from local through federal) and including
numerous surveillance systems to collect and share data for the understanding, prevention and
control of disease in the United States (Centers for Disease Control and Prevention, 2014b). The
NNDSS has evolved out of a need for state and local government to take action in response to
public health threats at the individual level. For example, the reporting of an individual case of
disease may result in isolation of the ill person and prophylaxis of the ill person’s direct contacts.
At the population level, information about the individual cases can be aggregated to paint
a community picture of disease that allows the citizens to understand the patterns and severity of
morbidity in the population. The data collected by the system are not collected to identify new
risk factors, but rather to describe how established risk factors are changing over time.
Additionally, the data can be used to generate hypotheses for additional studies; however, they
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do not contain a comparison group and cannot be used directly for hypothesis testing. As a result,
the NNDSS is designed to collect data that are analyzed using cross-sectional, descriptive
methods. The ongoing nature of data collection of NNDSS data allows for descriptive analysis of
the temporal aspect of the data, which can be used to describe changes in morbidity patterns over
time.
The NNDSS has a number of purposes related to national surveillance of disease, which
are described by the Centers for Disease Control and Prevention (2014b) as to:
•

collect, manage, share, analyze, interpret, and disseminate health-related data for statereportable and nationally notifiable diseases and conditions;

•

develop and maintain national standards—such as consistent case definitions and
electronic messaging standards;

•

monitor regional and national trends in diseases and health conditions;

•

work with other jurisdictions and partners to implement and assess prevention and control
programs;

•

designate certain diseases and conditions as nationally notifiable;

•

submit data on nationally notifiable diseases to CDC; and

•

maintain and publish the official national notifiable diseases statistics from 57 state,
territorial, and local reporting jurisdictions in the Morbidity and Mortality Weekly Report
(p. 1)
While the general operation of NNDSS is managed by the CDC, the system is based on

the United States’ federated legal model of public health. Congress is limited to the powers
specifically proscribed in the Constitution, leaving the general responsibility for public health to
the individual states and territories (Velikina, Dato, & Wagner, 2006). While the legal authority
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for surveillance rests at the state and local level, communicable diseases do not respect such
artificial divisions, and it is necessary for public health authorities to work together across
jurisdictional and state lines and at the national level to protect citizens from disease. The United
States system of disease surveillance evolved to standardize many aspects of the process while
allowing state and local health departments to retain their autonomy, providing the flexibility to
tailor the system to local needs. As a result, national disease surveillance in the United States is
not a single nationwide system, but rather a set of interconnected state systems with a
decentralized management structure and no legal requirement that states actually participate. It is
best described as being a “system of systems” rather than a single system (Adams, et al., 2014).
The tenth amendment of the United States Constitution reserves public health police
powers for the states (Hodge Jr., 1998). As a result, the legal authority to mandate the reporting
of conditions to the health authority rests with the individual state legislatures and is
implemented through a variety of legal means (Chorba, Berkelman, Safford, Gibbs, & Hull,
1989). Local health departments have occasionally mandated the reporting of additional diseases
at the city or county level based on the legal authority provided to the local health department in
a given state, although this process is not widespread in the United States (Allegheny County
Health Department, 2002; County of Los Angeles Department of Public Health, 2012; Colorado
Department of Public Health and Environment, 2005; Nevada Division of Public and Behavioral
Health, 2007).
There are 57 public health jurisdictions in the United States that voluntarily notify CDC
directly of nationally notifiable conditions (Centers for Disease Control and Prevention, 2014b)
through the NNDSS and would be considered “state-level” health departments. These include the
50 states, the five US territories (Guam, Puerto Rico, the US Virgin Islands, American Samoa

5

and the Commonwealth of Northern Mariana Islands), Washington DC, and New York City.
There are approximately 2,800 public health jurisdictions in the United States that are considered
to be “local” health departments that are organized under one of the state-level public health
jurisdictions and do not notify CDC directly of nationally notifiable conditions (National
Association of County and City Health Officials, 2014).
Individual states and territories are represented by the Council of State and Territorial
Epidemiologists (CSTE), which has been charged with the maintenance of the list of nationally
notifiable conditions since 1951. This includes modifying the list through adding and removing
conditions, developing the case definitions to be used in national notification and establishing
reporting criteria to be used at the state, territorial and local levels (Neslund, Goodman, Hadler &
Hodge Jr., 2008). Conditions are added to the NNC by a majority vote of states at the CSTE
Annual Conference, which is held in June. The additions, deletions and changes are then
forwarded to the CDC for inclusion on the NNC list for the following calendar year. Any
changes to the list are active as of the first day of Morbidity and Mortality Weekly Report
(MMWR) week 1 of the reporting year, which is the first week of the year (starting on Sunday)
that has four or more days in the calendar year (Centers for Disease Control and Prevention,
n.d.).
As recently as 1990, the inclusion of a disease on the list of nationally notifiable
conditions did not require the development of a standardized case definition for notification
purposes. In a 1990 publication, CDC and CSTE jointly established a set of uniform surveillance
case definitions for case notification, stating that “Surveillance demands uniformity, simplicity,
and brevity” (Wharton, Chorba, Vogt, Morse, & Buehler). They also cautioned that these case
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definitions were not sufficient to be used for patient care activities or “initiating public health
actions”.
Once a disease is added to or removed from the list of nationally notifiable conditions, it
is up to individual states to determine if they will add or remove the condition from the list of
reportable diseases within their jurisdiction and if so, determine the criteria by which the disease
will be made reportable. This includes the entities required to report, the criteria used to trigger a
report and the process by which the reported will be filed with the public health authority. These
all must occur within the constraints of the state’s established legal framework for disease
reporting. While this process allows states to tailor their disease reporting regulations to match
the needs of the population, it may introduce bias into a system that relies on consistency to
allow for the comparability of data across jurisdictions (Sacks, 1985).
Significance of the Study
The NNDSS serves as the primary data source for numerous studies on the incidence,
prevalence and risk factors for nationally notifiable conditions. Recent example of the uses of
NNDSS data include studies of the descriptive epidemiology of Hansen’s Disease (leprosy) in
the United States over a 15-year period (Nolen, et al., Incidence of Hansen's Disease — United
States, 1994–2011, 2014), a description of increasing incidence in primary and secondary
syphilis, especially in men who have sex with men (Patton M. E., Su, Nelson, & Weinstock,
2014), and an estimation of the number of actual acute hepatitis cases based on reported cases
(Klevens, Liu, Roberts, Jiles, & Holmberg, 2014). NNDSS data were also used widely as
performance metrics for the CDC in Director Dr. Thomas Frieden’s Congressional justification
of CDC’s Fiscal Year 2015 budget, including the number of incident cases of HIV, hepatitis A
and hepatitis B, and the incidence rates of gonorrhea, syphilis and tuberculosis, Escherichia coli
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O157:H7 infection, listeriosis and salmonellosis (Centers for Disease Control and Prevention,
2014a).
General guidelines on the use of NNDSS data state that “Surveillance practices, policies,
priorities, and resources vary from state to state. Therefore, one should use caution when making
state-to-state comparisons of disease incidence” (Centers for Disease Control and Prevention,
2001). Additionally, the NNDSS guidance cautions about temporal changes in the data collection
process, as state resources and public health priorities may shift, possibly resulting in an
inconsistent approach to surveillance for a given disease over time. In general, studies that use
NNDSS data typically are concerned about bias in the process of data collection, but this focuses
on incomplete disease reporting by clinicians and does not consider state-based reporting
differences when discussing limitations.
Purpose of the Study
The purpose of this study is to better understand the implementation of the disease
reporting and notification process at the state/territorial level in the United States, and to identify
areas for potential improvement. Differences in the implementation of the process by states may
result in problems with the validity of interstate comparisons of disease, and the degree to which
this is an issue has not been described.
The first goal of the study is to understand how states and territories individually
implement the reporting of nationally notifiable conditions and the factors that affect this
implementation. For this goal, the 2015 reportable disease lists for each state-level reporting
jurisdiction in the United States will be compared to the 2015 list of nationally notifiable
conditions. The comparisons will answer two broad questions:
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1. To what degree do all state-level public health jurisdictions require the reporting of
conditions on the 2015 nationally notifiable conditions list?
2. What factors, if any, predict state-level public health jurisdictions’ compliance with
including 2015 nationally notifiable conditions on the state reportable conditions list?
The second goal of this study is to understand how quickly state reportable conditions
lists are updated after a disease is added to the list of nationally notifiable conditions. For this
goal, the implementation timeline for state public health jurisdictions to include a nationally
notifiable condition on the list of state reportable diseases will be evaluated for a subset of
diseases that were added to the nationally notifiable conditions list from 1992-2012.
The third goal of this study is to evaluate the states implementation of disease reporting
requirements set forth in the CSTE position statement establishing a condition as nationally
notifiable. For this goal, the state reporting requirements from all state-level public health
jurisdictions for a subset of all notifiable conditions will be compared to the reporting
recommendations made in the formal process of adding a disease to the nationally notifiable
conditions list.
Key Terms
For the context of this study, definitions of relevant terms are provided below.
Case – A person who meets the clinical, laboratory, and epidemiologic criteria
established as part of a confirmed or probable case definition for a condition.
Condition – a state of health in a person.
Disease – a condition of the body or mind that impairs normal functioning.
Local health department – a unit of local or state government responsible for the
oversight of public health in a geographic area smaller than a state.
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Nationally Notifiable condition – a condition for which information about cases should
be transmitted to the CDC.
Notification – The process of a local or state public health authority submitting case
information to CDC of a condition on the Nationally Notifiable Condition list (Council of State
and Territorial Epidemiologists, 2015).
Public health jurisdiction – the state, county, city or regional governmental entity given
legal authority over public health matters in a geographic area.
Reportable condition – a condition that, when identified by a clinician, laboratory or
other entity designated by state law, must be reported to the public health jurisdiction as
specified by the state.
Reporting – The process of a healthcare provider, laboratory or other entity submitting a
case information to local or state public health of a condition under public health surveillance in
the jurisdiction (Council of State and Territorial Epidemiologists, 2015).
Reporting criteria – clinical, laboratory or epidemiologic findings which require a
clinician, laboratory or other designated entity to inform the state of the findings.
State-level public health jurisdiction – A public health entity responsible for notifying
CDC of nationally notifiable conditions through the NNDSS. For this project, these entities
include the 50 states, Washington DC, and New York City.
Summary
The NNDSS is the basis for morbidity surveillance in the United States and plays a key
role in scientific and public health policy decisions. While the system is generally organized
through the CDC at the national level, the constitutional underpinnings of public health place the
legal authority for public health reporting at the state and local level. Given this legal framework,
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NNDSS has evolved as a “system of systems” rather than a single, fully-integrated system.
Biases introduced into the disease reporting process have not been well described in the
literature, and as a result, concerns about the role of these biases are largely absent from
scientific and policy considerations.
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Chapter 2 – Review of Literature
“Good surveillance does not necessarily ensure the making
of the right decisions, but it reduces the chance of wrong ones.”
Alexander D. Langmuir, 1963
Introduction
When outbreaks of international concern occur, sensationalistic stories in popular media
usually remind the public that it doesn’t take long for disease to spread from a foreign part of the
world to their hometown. From reasonable headlines such as “Ebola: The world of global
infectious disease is getting smaller” (Samadi, 2014) to extreme headlines such as “You are not
nearly scared enough about Ebola” (Garrett, 2014), the public is reminded of the potential local
impact of diseases of international concern. While the media is often criticized that there is
“always money to be made in fear mongering” (Horgan, 2014), it is not inappropriate to consider
the local response to an outbreak if it were to spread locally.
The well-worn public health cliché that “all public health is local” is rooted in the idea
that, first and foremost, the citizens need to protect themselves. As public health systems evolved
in the United States, they were built around health departments at the state and local level, and
not the national level. The oldest health department in the United States is a local health
department and was founded in Boston in 1799 (Boston Public Health Commission, 2015). The
Centers for Disease Control and Prevention, the agency responsible for public health at the
national level, was not established until 1946 (Shaw, Goodman, Lindegren, & Ward, 2011).
Many of the challenges faced by disease surveillance systems today are a result of the
historical evolution of disease surveillance in the United States and its roots in the need for local
and state health departments to understand and respond to disease at the local level.
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The Historical Foundations of Disease Reporting
The systematic, population-based collection of disease statistics can be traced to a need
for governmental officials to understand the severity and spread of disease within their cities. In
1532, advisors to the King Henry VIII “commanded the mayor [of London] to certify how many
have died of the plague” (Creighton, 1891, p. 294). From this requirement, the Bills of Mortality
were first created, and provided weekly totals of deaths, separating out those from the plague, for
the parishes of London (Moriyama, Loy, Robb-Smith, Rosenberg, & Hoyert, 2011).
The Bills of Mortality were sporadically published during plague outbreaks throughout
the 16th century; they became consistently published on a weekly basis in 1611 by the
Worshipful Company of Parish Clerks (Slauter, 2011). The weekly reports listed the number of
deaths by cause, the parish in which the burial occurred, and the number of weekly christenings
(Parish Clerks of London, 1665). These weekly reports were far from complete, as they provided
no information on the decedent’s age and completely excluded those buried outside the church,
but they provided a basic insight into the health problems facing the people of London.
Nosology, the science of the classification of disease and the causes of death, was in its infancy,
as was the medical understanding of the cause of disease, so the accuracy of the classification of
causes of death is questionable (Moriyama, Loy, Robb-Smith, Rosenberg, & Hoyert, 2011).
However, these rudimentary reports provided a basic overview of disease at the population level
and served as the main source of health data for nearly three centuries, finding use throughout
the local response to disease (Slauter, 2011).
In 1663, John Graunt published “Natural and Political Observations Made upon the Bills
of Mortality”, a pioneering analysis that laid the foundation for the mathematical study of disease
at the population level and vital statistics, evaluating the age distribution and causes of death,
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birth rates and the growth of the population (Sutherland, 1963). Graunt was well aware of the
problem of misclassification of disease, and took steps to correct for this misclassification. As
Rothman described his process, “he considered the difficulty of outcome misclassification,
provided an estimate of its magnitude, and used that to correct for the misclassification”
(Rothman, 1996) While Graunt’s work provided the basis for an approach to understanding
disease at the population level, it was severely limited by the analysis of mortality, not morbidity,
data.
Near real-time reporting of ill persons is necessary for timely governmental intervention
to prevent the spread of disease in the population. In the United States, the first mandatory
disease reporting laws were passed in Rhode Island Colony in 1741. These laws required that
tavern owners report communicable diseases in their patrons to the local authorities. Two years
later, Rhode Island expanded this requirement to include the reporting of smallpox, yellow fever,
and cholera to local authorities by all citizens (Thacker, Qualters, & Lee, 2012).
In the 18th century, the term “surveillance” was used differently than it is used today, and
was directly tied to immediate government actions in response to disease. The historical process
of “surveillance” would be considered contact tracing and active monitoring today and was used
to observe the health of individuals so that they could be isolated if they were to develop disease,
as opposed to implementing broad quarantine measures for exposed individuals (Langmuir,
1976).
When the Tenth Amendment to the United States Constitution was ratified as part of the
Bill of Rights in 1791, all powers not specifically given to the federal government, including the
regulation of public health and welfare, were explicitly given to the states (Hodge Jr., 1998).
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With this amendment, states were free to develop (or not develop) their own reporting
requirements, processes, and responses.
In the mid-nineteenth century, the modern approach to disease surveillance was first
developed by William Farr, the head of the statistical department in the General Registrar’s
Office of England and Wales. Farr recognized the need for a population-based approach to
understanding disease and is often credited as the founder of modern disease surveillance
(Langmuir, 1976). Farr described his system based on having a “staff officer” (an
epidemiologist) in “every county or great city, with clerks to enable him to analyze and publish
the results of weekly returns of sickness to be procured from every district”, or by using the
postal system to send all the result to a central officer in London (Farr, 1875).
As an early proponent of population-wide, clinician-based disease reporting, Farr wrote
that it “will enable the therapeutists to determine the duration and the fatality of all forms of
disease under the several existing systems of treatment in the various sanitary and social
conditions of the people” (Farr, 1875). Farr’s philosophical approach to surveillance laid the
groundwork for the systems in place today (Susser & Adelstein, 1975), and his concept of a
postal-based reporting system was the primary method of disease reporting in the United States
for more than a century.
Massachusetts was the first state to implement a standardized disease surveillance similar
to the one described by Farr when the Massachusetts State Board of Health developed a
voluntary plan for the weekly reporting of diseases by a select group of sentinel physicians using
a standard postcard in 1874 (Thacker, Qualters, & Lee, 2012; Chorba, Berkelman, Safford,
Gibbs, & Hull, 1989). As described in the first report of the project, the goals were to understand
morbidity, as opposed to mortality, because “An entire hamlet may be smitten by an epidemic
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which makes no impression on the bills of mortality” (State Board of Health of Massachusetts,
1875). The system requested that physicians report weekly counts of 15 different conditions
categorized as mild or severe diseases: bronchitis, cholera infantum, cholera morbus, croup,
diphtheria, diarrhea, dysentery, influenza, measles, pneumonia, rheumatism, scarletina,
smallpox, typhoid fever and whooping cough.
The reliability of his record of observations depends upon his own acuteness and
judgment. He reports the presence or absence of diseases whose diagnosis is not always
easy. His opinion of the nature or gravity of any case or series of cases may be quite
different from that of his neighbor. What is diphtheria to one observer, is croup or simple
sore throat to another; what is febricula to one, is typhoid fever to another; what is
cholera infantum to one, is infantile diarrhoea to another; what is influenza to one, is
bronchitis or severe catarrh to another (pp. 480-481).
The solution enacted was to rely on the expertise of the clinicians chosen for participation
in their system, writing:
For this diversity there is no radical remedy. It is the source of a considerable margin of
error in the registration of mortality, affecting the causes of death; it is the possible origin
of a still wider range of uncertainty in the results of any scheme for registering diseases
which do not afford, in their fatal termination, an additional indication for diagnosis. Our
chief safe-guard is again to be found in the known skill and reputation of the observers.
(State Board of Health of Massachusetts, 1875, p. 481)
While this seems like a simple, if not unsatisfying, solution, it must be viewed in the
historical context of the medical profession at the time. The reputation of the observers truly was
of utmost importance, as mandatory medical licensing would not be implemented in
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Massachusetts until 1894, twenty years after the implementation of the disease reporting system.
The medical licensing board did not require that physicians obtain a medical degree until 1915,
and it was not until 1936 that the board required that the licensee had earned a medical degree
from a reputable school (Hamowy, 1979). While Massachusetts did recognize that a “purely
ideal system for registering prevalent sickness would involve the recording of every case of acute
disease”, it also recognized that it was not practical given the constraints of the system (State
Board of Health of Massachusetts, 1875, p. 480).
Michigan became the first state to require the reporting diseases by all physicians in
1883. Michigan statute stated that:
Whenever any physician shall know that any person whom he is called to visit or who is
brought to him for examination is infected with small-pox, cholera, diphtheria, scarlet
fever, or any other disease dangerous to the public, health he shall immediately give
notice thereof to the health officer, the president or the clerk of the board of health of the
township, city, or village in which the sick person may be (Compiled Laws of Michigan,
1883, 1734 § 43)
The list of diseases explicitly reportable in Michigan was much smaller than was
implemented in Massachusetts. However, the Michigan reporting law featured two aspects of
mandatory disease reporting that are routine features of disease reporting regulations today but
were not implemented in Massachusetts: application to all licensed physicians and a clause that
makes unspecified “dangerous diseases” reportable.
The next phase in the evolution of the process of disease surveillance in the United States
was the development of system that brought together the numerous state-based systems to
produce a national picture of disease. Congress first authorized the United States Marine
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Hospital Service, predecessor of the Public Health Service, to collect reports of communicable
diseases (cholera, plague, smallpox and yellow fever) from U.S. consuls in foreign countries in
1878. These reports were used to establish quarantine measures to prevent disease from being
imported into the United States. (Montalbano, et al., 1997) In 1893, Congress expanded the
Marine Hospital Service’s authority to collect information from states and local jurisdictions, and
in 1902, Congress passed the “Act to regulate appointments in the Marine Hospital Service of
United States", which required the Marine Hospital Service to publish forms for the standardized
collection of data for morbidity, mortality and vital statistics (United States Public Health and
Marine Hospital Service, 1903).
By 1901, every state had independently enacted mandatory disease reporting by
clinicians to state or local health authorities. However, all states did not voluntarily participate in
national disease reporting until 1928 (Thacker, Qualters, & Lee, 2012).
The final step in the evolution of the process of disease surveillance in the United States
was the standardization of nationally notifiable conditions across the states. When the CDC
assumed responsibility for national disease surveillance from the Public Health Service in 1946,
a number of conditions were reportable with a variety of frequencies (annually, monthly or
weekly).
In 1951, CDC epidemiology branch head Alexander Langmuir requested that the
Association of State and Territorial Health Officers convene a meeting of state epidemiologists
to determine which conditions were considered to be of national importance and should be
placed under national surveillance (Centers for Disease Control and Prevention, 1996). At this
meeting, forty-one conditions were placed under national surveillance and were to be reported on
a weekly basis.
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This meeting lead to the formation of the Council of State and Territorial Epidemiologists
(CSTE), an organization that is currently responsible for annually updating the list of nationally
notifiable conditions (CDC, 2014d). Based on a majority vote of member states at their annual
conference (held in June), CSTE makes a formal recommendation to the CDC to add a condition
to the list of nationally notifiable conditions. The Paperwork Reduction Act requires that all
federal agencies obtain Office of Management and Budget (OMB) approval prior to collecting
data, a process that takes at least six to nine months (typically 18 months) for approval (Coates &
Aranas, 2013). Once OMB approval is granted, the condition is officially added to the list of
nationally notifiable conditions.
In 1990, CDC and CSTE epidemiologists published a set of standardized case definitions
to be used for the notification of nationally notifiable conditions from states to the CDC
(Wharton, Chorba, Vogt, Morse, & Buehler, 1990). The authors described the purpose of the
definitions as for disease notification and noted that “requirements for reporting diseases are
mandated by state laws or regulations, and the list of reportable diseases in each state varies” (p.
1); however, they did not recommend that states develop standard criteria for reporting.
The list of nationally notifiable conditions has been modified annually by the members of
CSTE through the addition of conditions, removal of conditions and the updating of case
definitions. The most recent addition to the list of was campylobacteriosis for 2015 (Bradlek,
DeMaria Jr, & Geissler, 2014), bringing the total number of nationally notifiable conditions to
108 unique infectious conditions and subconditions, five non-infectious conditions and two types
of outbreaks (CDC, 2014c).
Nowhere in public health is the cliché that “all disease is local” more evident than in the
history and development of disease surveillance in the United States. While national statistics are
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compiled to give a larger picture of disease, the legal basis and day-to-day work of conducting
disease surveillance rests at the state and local level. Adams et al. (2014) summarize the NNDSS
and the United States’ approach to surveillance as:
NNDSS is neither a single surveillance system nor a method of reporting. Rather, it is a
'system of systems', which is coordinated at the national level across disease-specific
programs in order to optimize data compilation, analysis, and dissemination of notifiable
disease data (p. 2).
Legal Basis of Disease Reporting
In the United States, the responsibility of protecting the public’s health falls to the
individual states and territories. As a result, the legal basis for disease reporting is distributed
through numerous legal requirements throughout the country. Each state and territory has a legal
mechanism for disease reporting that is unique to that jurisdiction. Some states include disease
reporting in state statutes, while others require disease reporting under broad authority given to
the health departments and health officers (Neslund, Goodman, Hodge Jr., & Middaugh, 2010).
This variation can also exist within a state, as counties and cities may have the legal
authority to adopt their own reporting regulations in addition to existing state laws. For example,
in Nevada, the legal basis for public health reporting exists through a combination of state
statute, administrative code and local regulations. Nevada statutes establish the State Board of
Health and provide broad power to adopt regulations (Nevada Revised Statutes 439:
Administration of Public Health, 2013). The statute also provides the legal basis for the
establishment of local (county or city) health departments and grants the local board of health
authority to “Adopt such regulations as may be necessary for the prevention, suppression and
control of any contagious or infectious disease dangerous to the public health”.
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In Nevada, the district health officer is given broad power to protect the public’s health
and may require the additional reporting of an infectious disease in addition to those specific as
being reportable state-wide in administrative code (Nevada Administrative Code Chapter 441A:
Infectious Disease and Toxic Agents, 2011). Based on this regulation and the broad powers to
adopt public health regulations (Nevada Revised Statutes 439.366.3(d), 2013), the Southern
Nevada District Board of Health adopted regulations for the reporting of diseases, which made
ten additional conditions reportable in Clark County but not other counties of the state (Southern
Nevada District Board of Health, 2006).
The process of adding locally-reportable conditions as was done in Clark County is
unique to Nevada, as Nevada’s statutes and regulations share neither a common origin nor a
common evolution with the statutes regulations any of the other states. An evaluation of the
reporting laws of the states and territories by Gostin, Burris, & Lazzarini (1999) found that:
The law in many states consists of successive layers of statutes and amendments, built up
over one hundred years or more in response to disease epidemics. Although states
sometimes follow each other in crafting legislation focused on particular topics, the
health codes in their entirety have evolved independently, leading to profound variation
in the structure, substance, and procedures for detecting, controlling, and preventing
communicable diseases. (p. 73)
In some states, these regulations have changed very little since their introduction over a
century ago. Gostin, Burris, & Lazzarini (1999) identified that in South Dakota, “The state code's
chapter on disease control begins with six sections passed between 1877 and 1915, which have
not been substantively amended since 1939” (p.74)
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If two states choose to require that the same disease be reported within their jurisdiction,
the process by which diseases are reported to the jurisdiction may be highly variable as well. A
review of influenza laws initiated because of the 2009 H1N1 Influenza outbreak by Danila, et al.
(2015) found that:
Reporting laws vary by state regarding which diseases must be reported, who must
report, whether case laboratory specimens must be submitted, and other features. This
variation could affect a national public health response to a public health emergency,
because federal health officials rely on voluntary reporting of epidemiological data from
states to the Centers for Disease Control and Prevention (p 13).
While half the states in Danila’s study required the reporting of influenza-associated
pediatric mortality, only ten percent required the reporting of all age influenza-associated
mortality. While most states required reporting by physicians and laboratories, some also
required that coroners and medical examiners had to report (as deaths were not required to be
reported in all states). Twenty percent of states required reporting of suspect cases in addition to
confirmed cases. In summary, the study found wide variation in how states require the reporting
of influenza. Similar studies have not been reported on the legal reporting requirements of other
diseases.
Bias
One key attribute of an effective surveillance system is that it accurately represents the
occurrence of the condition of interest in the population under observation. While it is unrealistic
to expect that every case of disease in population will be identified by the system, the system
should consistently identify a subset of representative cases over time (German, et al., 2001).
Kimball, Thacker and Levy came to a similar conclusion, noting that “Certainly underreporting
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is not a problem if reported cases truly reflect disease activity and are obtained in a timely
manner” (1980, p. 166).
Infectious disease reports are frequently described as being the “tip of the iceberg” in that
the reported cases are only a small fraction of the total cases of disease in a population
(Louisiana Office of Public Health Infectious Disease Epidemiology Section, 2014; Hunter &
Scallen, 2010; Simcoe Muskoka District Health Unit, 2010). The unreported cases are not one
homogeneous group, and consist of subgroups of undiagnosed, untested, and unreported cases.
Each step between the occurrence of disease and the reporting of the case to the public health
jurisdiction is an opportunity for bias to be introduced into the system, and differences in these
biases between reporting jurisdictions can increase the difficulty of comparing results across
multiple jurisdictions.
Once a disease occurs in a person, that person must seek care for their illness, and the
proportion of people in a population seeking care varies by condition and severity. Patients will
not seek care for a number of reasons, including being unemployed, being uninsured and not
having a healthcare provider (Biggerstaff, et al., 2014). The proportion of cases tested for a
particular disease (which is required of nearly all conditions on the nationally notifiable
conditions list) also varies by condition and the severity of clinical presentation. It may also vary
with the clinician’s knowledge of the incidence in the population; for example, a clinician may
not elect to test for influenza at the height of influenza season given the increased predictive
value positive of a clinical diagnosis. If a test is ordered, it must detect the presence of the
disease, which is dependent on the sensitivity of the test. Finally, the laboratory result or clinical
diagnosis based upon that laboratory result must be reported to the public health authority (Reed,
et al., 2009).
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Reasonable assumptions can be made about the consistency across reporting jurisdictions
at each of these steps. Care-seeking behavior should be consistent across jurisdictions in the
United States. A mathematical modelling study on 2009 H1N1 influenza reviewed several
published studies on care-seeking behavior and found that roughly 50% of people sought care for
influenza across multiple jurisdictions and settings (Reed, et al., 2009). The same consistency
was identified for clinician testing for influenza, and the sensitivity of testing is consistent across
jurisdictions, as it is based on the methodology used for testing itself.
Reporting by clinicians and laboratories appears to be consistent across states. A 2002
analytic literature review of 33 studies conducted between 1970 and 1999 found that disease
reporting completeness is most highly correlated with the type of disease being reported, with
completeness ranging from 9% to 99%. The review also found that reporting completeness
varied by condition but was generally unaffected by geography (Doyle, Glynn, & Groseclose,
2002). The results of this study must be interpreted carefully, as it included multiple studies with
small sample sizes (as few as 16 cases), did not represent the breadth of types of diseases that
were reported, evaluated both active and passive surveillance approaches and treated mortality
and hospitalization reporting as being the same as morbidity reporting. However, there is no
indication that larger sample sizes would identify significant geographic differences among the
relevant studies.
The identified reasons for underreporting included a lack of awareness that there was a
legal requirement to do, a lack of knowledge about how to report and to whom to report,
confidentiality concerns, and a reliance on someone else (such as a laboratory) to file the legallymandated report. These reasons were the same ones identified by Silk and Berkelman (2005),
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and the strategies Silk and Berkelman propose to improve clinician reporting would apply
irrespective of geography
As the Nationally Notifiable Diseases Surveillance System is a “system of systems”, the
representativeness of the system and the types and extent of bias must be consistent across those
jurisdictions for data to be comparable across different reporting jurisdictions. The need for
consistent data was described in early surveillance system proposals of the late 19th century, but
remains an unresolved issue over a century later.
Development of Case and Reporting Definitions
A survey conducted by CSTE in 1984 found that “substantial variations in case
definitions of reportable diseases, criteria for counting as a case, and sources of surveillance” and
advocated for the development standardized case definitions for all nationally notifiable
conditions (Sacks, 1985).
In 1990, a set of standardized case definitions were released for use by local and state
health departments in evaluating disease reports to determine if the CDC should be notified
(Wharton, Chorba, Vogt, Morse, & Buehler, 1990). While the authors expressed the hope that
“the incidence of reported diseases in different geographic areas may be more meaningfully
compared”, standardized case definitions do not completely remedy this problem. Sacks (1985)
stated that people using the NNDSS data “need to be aware of the limitations of these data
because of the differences in case counting and ascertainment practices” (p. 1422); the case
definitions solved the issue of differences in case counting, but not in case ascertainment.
An update to the case definitions was published in 1997 based on changes approved by
CSTE. Both the 1990 publication (Wharton, Chorba, Vogt, Morse, & Buehler, 1990) and 1997
publication (Koo, Wharton, & Birkhead, 1997) provides a brief summary of the need for
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surveillance; differences in the language between these two publications hint at changes in the
way the view of surveillance had changed. In 1990, the basic needs of the system were described
as “uniformity, simplicity, and brevity”. As the demand for data on notifiable conditions
increased and the desire to have timely data in order to be able to respond to cases of disease, this
description changed to “uniformity, simplicity, and timeliness” in 1997.
More importantly, one change in phrasing hints at how epidemiologists saw the role of
these case definitions in public health. In 1990, readers were cautioned not to use the case
definitions as “sole criteria for establishing clinical diagnoses, determining the standard of care
necessary for a particular patient, setting guidelines for quality assurance, providing standards for
reimbursement, or initiating public health actions”. In 1997, the phrase “or initiating public
health action” was removed, blurring the line between definitions used for case notification and
criteria used for case reporting by clinicians and laboratories. This is reflected in disease
reporting laws in Nevada, where regulations passed in 1992 adopted the national case definitions
and required clinicians to report “cases” and “suspected cases” of disease (Nevada
Administrative Code Chapter 441A.200, 2011).
In 2007, CSTE passed a position statement which provided a standard format for placing
diseases on the NNC list. This included a requirement that authors provide the criteria used to
determine when a clinician, laboratory or other reporting entity should make a report to the
health authority (Macdonald, 2007). As a result of this position statement, all diseases on the
NNC list were reevaluated, reporting criteria were added to the national case definition, and all
newly-added conditions were required to include the same criteria. Although the reporting
criteria have been in place for several years, no published studies have been identified that have
evaluated their inclusion in state reportable disease criteria.

26

Evaluation of the National Notifiable Disease Surveillance System
In 2001, the CDC updated guidelines for the evaluation of public health surveillance
systems in order to account for changes in public health informatics, including data exchange
and system integration (German, et al., 2001). However, as a “system of systems”, NNDSS
cannot be fully evaluated using the CDC’s guidelines, as many evaluation tasks are not suited to
the distributed nature of the system. Additionally, the guidance has no provision for evaluating
the “system of systems” approach. For example, the guidance assumes that the legal authority for
implementation of the system is consistent across all portions of the system, and does not provide
for the evaluation of differences across states.
In August of 2011, the CDC initiated an external functional evaluation of the all aspects
of the NNDSS. The first phase was conducted within CDC to evaluate the business goals,
processes and critical shortcomings of the system, as well as to make recommendations for
improvement that could be made at the CDC (Smith, Kriseman, & Kirkwood, 2011). They found
that the NNDSS lacked “a consistent, national (both within and outside CDC), long-term
oversight or governance mechanism to guide NNDSS strategically” (p. 3). Much of this
inconsistency is due to the system serving different purposes for the local, state and federal
stakeholders. Smith, Kriseman and Kirkwood (2011) described these differences as
State and local health departments see this reporting system’s main function as the means
to receive actionable information to allow them to intervene and manage disease, and
secondarily to report to CDC, produce reports of communicable diseases, and conduct
analytic studies. CDC staff see NNDSS primarily as a mechanism of receiving accurate
and timely information on notifiable cases for national surveillance tracking, special
studies, and, where indicated, reporting to the World Health Organization. (p. 9)
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While this analysis hints at the underlying reason for interstate differences in the NNDSS, it does
not specifically address the issue of the impact of disease reporting to the states.
The second phase of the evaluation “addressed the needs and perspectives of state and
local health departments about infectious disease surveillance within NNDSS” (Council of State
and Territorial Epidemiologists, 2012). The major focus of the evaluation was the technical
framework of the National Electronic Disease Surveillance System (NEDSS), which is the
umbrella term encompassing systems used to conduct investigations and notify CDC of
confirmed and probable cases. Respondents identified confusion about the meaning of acronyms
NNDSS and NEDSS as an issue; the survey did not help clarify the matter, as it was more of an
evaluation of the NEDSS than NNDSS, despite the name of the report. As in phase one, phase
two did not address the underlying legal framework for reporting or any of the criteria used for
disease reporting within a state or local health department. Also as with phase one, the
assessment provided little relevant analysis of the underlying theoretical framework of NNDSS.
Evaluation of State Reporting Practices
Research on state reporting requirements has not been widely conducted and has been
limited to determinations of which diseases are reportable in which states (Fowler, 1944;
Rousch, Birkhead, Koo, Cobb, & Fleming, 1999; Jajosky, et al., 2011). As disease reporting
occurs at the state and local level, the reporting requirements of neighboring jurisdictions are of
little interest to clinicians and laboratories, and summary articles of disease reporting practices
are of little value to the mandated reporters.
Since 2008, CSTE and CDC have conducted the State Reportable Conditions Assessment
(SRCA), an annual joint survey to determine which diseases are legally reportable in each statelevel jurisdiction. The SRCA surveys state epidemiologists to determine if a given condition is
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reportable within the jurisdiction, the groups required to submit a report, and the timeframe in
which reports must be submitted (Council of State and Territorial Epidemiologists, 2013). As not
all conditions are reportable in all states, the results of the survey are used to calculate the
population denominator for calculating disease-specific rates (Ferland & Jajosky, 2011).
The SRCA has been evaluated in only one published article; the most significant finding
was that many states do not explicitly require that certain diseases be reported, but rather rely on
implicit reporting requirements, which could pose a challenge for the automation of case
reporting. Some diseases are reportable under broad categories such as “rare diseases of public
health importance”; for example, Coccidioidomycosis is implicitly reportable in 25% of the
states and territories as a rare disease (Jajosky, et al., 2011).
The concerns about implicit reporting of disease raised by Jajosky are of concern to a
joint CDC/CSTE/Association of Public Health Laboratories initiative, the Reportable Condition
Knowledge Management System (RCKMS), a project to create a machine-readable database of
all permutations of disease reporting in order to facilitate automated electronic disease reporting
(Altamore, Conn, Staes, & McGarvey, 2013). If the RCKMS is ultimately successful, it will still
not address the problem of different disease reporting criteria resulting in data that cannot be
compared across states. While the system does catalog the reporting requirements by state and is
intended be used by clinicians, hospitals and laboratories to determine what is reportable in a
jurisdiction, it is not intended to eliminate differences between states or to create a standardized
technical reporting framework.
Jajosky et al. (2011) also identify a limitation of the design of the SRCA: “although
SRCA supports information needs for surveillance, this assessment does not support the realtime needs of reporting entities” (p. 256). While the SRCA collects data about reportable disease
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in a standardized format, such a format is not made available by states to clinicians, laboratories
and other reporting entities and may be up to interpretation by clinicians.
Additionally, CDC uses a hierarchy in the evaluation of SRCA data to determine if a
particular disease is reportable; for example, if “poliovirus (not further specified)” is listed as
being reportable, a more specific disease such as “poliomyelitis, paralytic, vaccine associated”
would also be considered to be reportable (Jajosky, et al., 2011). While this designation may be
easily understandable to the epidemiologists that work with polio, subtle differences between the
conditions may not be as obvious to clinicians and may result in over- or under-reporting.
Not included in the 2008 SRCA, but included in later SRCA surveys, are broad, nonspecific categories that might result in the identification of a case at the state or local level. For
example, if the law requires that all cases of “acute hepatitis” be reported and the health
department then performs testing to determine which virus is causing the infection, cases of
acute hepatitis A, B, or C could be discovered. The same is true for acute flaccid paralysis case
reports resulting in the identification of polio or hemolytic uremic syndrome reports resulting in
the identification of Escherichia coli O157:H7.
A major limitation of the SRCA is that it views state reportable diseases from the
perspective of the public health department and not the clinician or other required reporter. States
are encouraged to have subject matter experts complete the sections related to their expertise
(Council of State and Territorial Epidemiologists, 2013), which may result in a biased view of
reporting requirements especially within broad categories that make a number of conditions
implicitly reportable. As the system is passive and is dependent is on clinicians to make the
effort to report disease, a better evaluation of the system would be based on the clinician’s
perspective of what is reportable.
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Use of the Data
While little research on the processes of disease reporting through the NNDSS has been
conducted, data generated by the system are widely published and serve as the basis for scientific
inquiries, policy discussion and funding decisions. Data from the NNDSS are published weekly
in the Morbidity and Mortality Weekly Report, the CDC’s journal of public health surveillance,
in a section entitled “Notifiable Diseases and Mortality Tables”. This table provides weekly
provision counts of nationally notifiable diseases submitted to the CDC. The final issue for each
year (typically published 18 to 24 months after the completion of the year) is the finalized
“Summary of Notifiable Diseases” (Teutsch, 2010).
The NNDSS serves as the primary data source for numerous articles. Recent example of
the uses of NNDSS data include studies of the descriptive epidemiology of Hansen’s Disease
(leprosy) in the United States over a 15-year period (Nolen, et al., 2014), a description of
increasing incidence in primary and secondary syphilis, especially in men who have sex with
men (Patton M. E., Su, Nelson, & Weinstock, 2014), and an estimation of the number of actual
acute hepatitis cases based on reported cases (Klevens, Liu, Roberts, Jiles, & Holmberg, 2014).
NNDSS data were also used widely as performance metrics for the CDC in Director Tom
Frieden’s Congressional justification of CDC’s FY2015 budget, including the number of incident
cases of HIV, hepatitis A and hepatitis B, and the incidence rates of gonorrhea, syphilis and
tuberculosis, Escherichia coli O157:H7 infection, listeriosis and salmonellosis (Centers for
Disease Control and Prevention, 2014a).
Summary
Guidelines for the use of NNDSS data specifically issue the warning that “Surveillance
practices, policies, priorities, and resources vary from state to state. Therefore, one should use
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caution when making state-to-state comparisons of disease incidence” (Centers for Disease
Control and Prevention, 2001). Given the wide range of uses of the NNDSS data, a better
understanding of the limitations of the process of data collection is of vital importance to the
interpretation of a core set of data used in public health in the United States. Variation in the
reporting process between states creates an issue that is central to this study: differences in
disease reporting requirements among states can lead to selection bias in the inclusion of
potential cases of disease. While this bias would be consistent for a given state over time
(assuming that their reporting process was consistent), disease from different states may not be
directly comparable and may lead to misleading conclusions.
When Ida Sherman and Alexander Langmuir, the first heads of statistics and
epidemiology at the newly-formed CDC made the case for national disease reporting, they
described one of the limitations of clinician-based passive surveillance as the “incomplete
etiological definition of reportable disease entities” and stated that the numerous limitations
“may be eliminated gradually through a study of the particular disease in specific areas, but other
flaws will probably always remain” (Sherman & Langmuir, 1952). To this day, the impact of
state-based differences in disease reporting is still not well described.
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Chapter 3 – Methods
Introduction
The NNDSS provides a number of recommendations to states on the establishment of
reportable conditions. While it does not require that any conditions be made reportable within the
state, it does provide guidance on how states can ensure consistency of reporting by providers to
the state and local health departments and notification of disease to the CDC if a state chooses to
make a disease reportable. The overall purpose of this study is to describe the implementation of
disease reporting within the United States at the state/territorial level, explore the factors
associated with differing implementations and to describe how the varying implementation
affects the validity of interstate comparisons of disease.
Research Questions and Hypotheses
This study consisted of four main research questions focusing on the NNDSS. The
research questions were independent of each other, and each required separate data collection.
For some research questions, the variables were separated into high and low dichotomous
categories based on a comparison to the group median.
Research Question One
For 2015, do all state-level public health jurisdictions require the reporting of conditions
under any category of reporting (i.e. explicitly, more broadly, or more narrowly) on the 2015
nationally notifiable conditions list?
Hypothesis for Question One
Ho:

For 2015, all state-level public health jurisdictions do not mandate the reporting
of all conditions under any category of reporting on the 2015 nationally notifiable
conditions list.
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Ha:

For 2015, all state-level public health jurisdictions mandate the reporting of all
conditions under any category of reporting on the 2015 nationally notifiable
conditions list.

Research Question Two, Part One
What state-specific factors, if any, are associated with a state including a greater than
median number of 2015 nationally notifiable conditions on their respective state’s 2015
reportable conditions list?
Hypothesis for Question Two, Part One
Ho:

No state-specific factors are associated with a state including a greater than
median number of 2015 nationally notifiable conditions on their respective state’s
2015 reportable conditions list.

Ha:

One or more state-specific factors are associated with a state including a greater
than median number of 2015 nationally notifiable conditions on their respective
state’s 2015 reportable conditions list.

Research Question Two, Part Two
What condition-specific factors, if any, are associated with a condition being including on
a greater than median number of 2015 state reportable conditions lists?
Hypothesis for Question Two, Part Two
Ho:

No condition-specific factors are associated with a condition being included on a
greater than median number of 2015 state reportable conditions lists.

Ha:

One or more condition-specific factors are associated with a condition being
including on a greater than median number of 2015 state reportable conditions
lists.
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Research Question Three
Do a majority of state-level public health jurisdictions add conditions to their list of statereportable conditions within 18 months after they have been added to the list of nationally
notifiable conditions?
Hypothesis for Question Three
Ho:

A majority of state-level public health jurisdictions do not add conditions to their
list of state-reportable conditions within 18 months after they have been added to
the list of nationally notifiable conditions.

Ha:

A majority of state-level public health jurisdictions add conditions to their list of
state-reportable conditions within 18 months after they have been added to the list
of nationally notifiable conditions.

Research Question Four
Do state-level public health jurisdictions utilize the same reporting criteria as in the
official reporting recommendation for diseases reportable within the jurisdiction?
Hypothesis for Question Four
Ho:

Reporting jurisdictions mandate the reporting of conditions on the nationally
notifiable conditions list utilizing the same reporting criteria as in the
recommendation.

Ha:

Reporting jurisdictions do not mandate the reporting of conditions on the
nationally notifiable conditions list utilizing the same reporting criteria as in the
recommendation.
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Study Population
The subjects included in descriptive portions of this study were the state-level public
health reporting jurisdictions in the United States that directly notified the CDC of notifiable
conditions in 2015. These jurisdictions included the 50 states, Washington DC, and New York
City, NY. For the analytic portions of this study, Washington DC and New York City, NY were
excluded as they were not included in the state-level evaluations being used as sources of data.
The five US territories (Guam, Puerto Rico, the US Virgin Islands, American Samoa and the
Commonwealth of Northern Mariana Islands) were also excluded from all analyses, as they have
historically not fully participated in the NNDSS.
Data Sources
The main sources of data for this project were the list of Nationally Notifiable Conditions
on the CDC website, documents related to the NNDSS posted on the CDC website, CDC
publications of weekly or annual disease statistics, and individual reporting jurisdiction websites
listing the state-reportable conditions. Additionally, the CSTE position statement (and official
CDC response to the position statement) that added the condition to the list of nationally
notifiable conditions was used as a data source and as documentation to resolve any issues with
the interpretation of the notifiable condition.
Data Management and Analysis
State reportable condition data were identified on state and county health department
websites and hand-entered onto paper data collection forms. The data from the paper forms were
manually entered into Microsoft Excel 2013 then imported into a Microsoft Access 2013
database developed for the project. Data were compared against the state websites to identify and
correct any data entry errors. Condition names were manually standardized to the names on the
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NNC list, and all nationally notifiable conditions recorded as not being reportable in a state were
confirmed by a review of the state’s reportable condition list, state regulations and state disease
statistics. Data analysis and visualization was performed using Microsoft Excel 2013 and SPSS
21.
Research Question One Methods
To understand the general reporting structure in each state-level jurisdiction (state), the
section of the state health department’s website pertaining to the reporting of disease was
identified through internet searches and evaluated to answer the following questions:
•

Did the state provide the required reportable conditions in a summarized (list) format
(as opposed to a reference to a legal document)?

•

Did the state provide legal citations for the reporting of disease?

•

Did the state provide a list of the standard codes for clinician reporting, e.g.,
Systematized Nomenclature of Medicine (SNOMED), International Statistical
Classification of Diseases and Related Health Problems version 9 (ICD9) or version
10 (ICD10)?

•

Did the state provide a list of the standard codes for laboratory reporting, e.g., Logical
Observation Identifiers Names and Codes (LOINC), SNOMED?

•

Did the state provide forms for the reporting of suspect cases?

•

Did the state provide an on-line method for the reporting of suspect cases?

•

Did the state provide instructions on how disease reports should be submitted?

•

Did the state have a separate reportable condition list for laboratories and clinicians?

•

When was the list last updated?

•

When was the website last updated?
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•

Did the state provide a disease reporting poster (either directly printable or that could
be ordered)?

•

Was the state’s reporting website up to date (as compared to the date the list was last
updated)?

Additionally, the 2015 state reportable disease list from each of the 52 state-level
jurisdictions was collected from the individual state health department websites, when available.
If the state website did not provide such a list, the list was identified from local public health
jurisdictions within that state.
The list of nationally notifiable conditions as of January 1, 2015, was abstracted from the
Centers for Disease Control and Prevention’s NNDSS website. Healthcare-acquired infections
were excluded from this analysis, as they are reported through a separate system.
Each state reportable condition list was reviewed to determine which nationally notifiable
conditions were reportable in the state. The reporting requirement was classified as:
•

Explicit: the NNC was explicitly listed as a reportable condition for the state.

•

Broader: the NNC was listed as part of a broader category of explicitly reportable
conditions within the state. For example, pediatric influenza deaths would be classified as
“explicit, broader” if all influenza deaths were reportable in the state. An NNC was not
classified under very broad categories such as “diseases of public health concern” without
further specification.

•

Narrower: only a subset of the NNC was explicitly reportable in the state. As an example,
Spotted Fever Rickettsiosis would be classified as “explicit, narrower” if the state
required the reporting of Rocky Mountain Spotted Fever.
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•

Not Reportable: the condition was not explicitly reportable within the state under one of
the above categories.

For each nationally notifiable condition reportable in a state, the timeframe in which it must be
reported, and the people or organizations who must report conditions were also identified.
State-reportable conditions that were not nationally notifiable were identified from the
states’ reportable disease list, standardized and entered into the database as well.
Conditions that have been removed from the nationally notifiable conditions list were
identified by evaluating CSTE position statements, CDC disease reports and published articles
about the NNDSS.
Descriptive statistics for research question one were calculated for both states and
conditions, including the overall state reporting requirements, disease reporting by state and
population, timeframes for state reporting, required reporting entities and state reporting of
NNCs, former NNCs, and non-NNCs.
Research Question Two Methods
For research question two, part one, state statistics and public health rankings were
collected for the 50 states (excluding Washington D.C. and New York City) as independent
variables, including:
•

From the report “America’s Health Rankings”:
•

Overall state health ranking (United Health Foundation, 2014)

•

Physicians per 100,000 population (United Health Foundation, 2014)

•

From the Trust for America’s Health/Robert Wood Johnson Foundation:

•

FY 12-13 State public health funding and per capita funding (Levi & Segal, 2014)

•

FY 12-13 CDC public health funding and per capita funding (Levi & Segal, 2014)
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•

From the United States Census Bureau population estimates and American Community
Survey:
•

Population (United States Census Bureau, 2014a)

•

Population density (United States Census Bureau, 2014b)

•

Educational attainment (United States Census Bureau, 2012)

•

From the National Immunization Survey:

•

2013 4:3:1:3:3:1 immunization coverage (Centers for Disease Control and
Prevention, 2013)

•

From the Emerging Infections Program:
•

2015 program participation (Centers for Disease Control and Prevention, 2015).

For research question two, part one, the number of NNCs and the number of non-NNCs
reportable in each state were calculated from the data collected and analyzed. State-specific
factors and the number of reportable conditions were categorized into high and low dichotomous
categories based on a comparison to the group median. Statistical analysis was conducted using
SPSS 21.0 for Windows. Chi-square tests of independence were conducted for each statespecific factor and number of reportable conditions. Additionally, correlation coefficients were
calculated for the strength of association between state-specific factors and number of reportable
conditions using the Pearson correlation coefficient with a two-tailed test for significance.
For research question two, part two, condition characteristics were determined for each
NNC and categorized as dichotomous (yes/no) variables, including:
•

Inclusion as a “Category A” bioterrorism condition by the CDC (Meselson 2002).

•

A condition being vaccine-preventable.
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•

The CDC notification urgency category (Centers for Disease Control and Prevention
2014e).

The number of states the NNCs were reportable in were categorized into dichotomous
high and low categories based on a comparison to the group median. Statistical analysis was
conducted using SPSS 21.0 for Windows. Chi square tests of independence were conducted for
the strength of association between each condition-specific factor and number of states in which
the NNC was reportable.
Research Question Three Methods
Conditions added to the NNC between 1992 and 2012 were identified using CSTE
position statements, CDC weekly and annual summaries published in the Morbidity and
Mortality Weekly Report and NNDSS documentation from the CDC website. Conditions were
excluded from further analysis if they were not included in CDC summary publications with
state-specific data (i.e. counts are only reported in aggregate for all states) for the necessary time
periods, or were subcategories of a larger parent category that may not require changing of
disease reporting regulations, for example, if deaths from an existing NNC were added to the
NNC list, or were not reported through NNDSS but were reported through other mechanisms or
systems.
For each condition included, the MMWR publications and summaries of nationally
notifiable diseases for the year in which the condition was added and subsequent years was
reviewed to determine if and when the disease was added to the state’s list of reportable diseases
during the study period. The MMWR Summary of Notifiable Diseases for the year in which the
condition was added to the NNC list to determine in which states it was reportable during the
first year it was nationally notifiable (the summary lists the total number of cases in each year,
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and indicates states for which the condition was not reportable). For states in which the disease
was not reportable in the first year, subsequent annual summaries were iteratively reviewed until
the year it was made reportable in the state was identified. As 2013 and later summaries had not
been published at the time of the data collection, the MMWR report for the first week of July in
2013 through 2015 was reviewed to determine if the condition was reportable in those years. A
condition was considered reportable for a state if that state had reported any cases in that year.
CDC requires that a condition must be reportable for at least six months to be considered
reportable for the year; a condition reportable in early July would meet this threshold, and those
made reportable after that point would not.
This six-month requirement was use to set the 18-month cutoff for this research question.
In order to be considered reportable in the year it was added to the list, it would need to be added
to the state’s reportable conditions list within the first six months of the year. Given that states
typically follow a complicated legal process to make the condition reportable, allowing only six
months to complete this process is unreasonable expectation. An 18-month cutoff was selected to
provide states an opportunity to add the condition to their reportable list, and would result as the
condition being listed as reportable by the CDC in either the year it was added to the national list
or the subsequent year (year zero or one).For each selected condition, the time to addition to a
state reportable list was calculated and evaluated against the cutoff.
Research Question Four Methods
Four nationally notifiable conditions were selected for detailed analysis based on their
frequency of reporting, importance to public health and the complexity of recommended criteria
for reporting. These selected conditions were: elevated blood lead levels, influenza-associated
pediatric mortality, Shiga toxin-producing Escherichia coli, and Tuberculosis.
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The most recent CSTE position statement for each NNC was downloaded from the CSTE
website. State reportable condition list information, disease reporting guides and state regulations
were reviewed for each state, and the recommendation set forth in the CSTE position statements
for the reporting of a disease to a state was compared against the state’s reporting requirements.
For this project, a “reporter type” is defined as the category of individuals or
organizations that, because of their professional license or function (e.g., physicians, nurses,
hospitals, laboratories), must submit a report of a condition to a state or local health department
when the condition is identified. The reporter types in each state were compared to the national
recommendation and were categorized as:
•

Not reportable in the state.

•

More reporter types were required to report than the national recommendation.

•

The same reporter types were required to report as the national recommendation.

•

Fewer reporter types were required to report than the national recommendation.

They were also categorized for clinical and laboratory criteria that necessitate a report as:
•

Not reportable in the state.

•

Broader criteria to initiate a report than the national recommendation.

•

The same criteria to initiate a report as the national recommendation.

•

Narrower criteria to initiate a report than the national recommendation.

•

The condition was reportable, but the criteria to initiate a report are not provided by a
state.

Descriptive statistics were calculated for each selected NNC, including the number and
percent of states requiring reporting of the NNC, grouped by the above-listed classifications.
Human Subjects Protections
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The Code of Federal Regulations (CFR) governing the protection of human subjects
defines a human subject as follows:
Human subject means a living individual about whom an investigator (whether
professional or student) conducting research obtains
(1) Data through intervention or interaction with the individual, or
(2) Identifiable private information (Protection of Human Subjects, 2009)
All data collected in this study pertained to the process of disease reporting and did not
include actual data collected from human subjects. As such, the data collection in this project
was not covered by 45 CFR part 46 (see Figure 1), and therefore it did not require review or
approval by the Institutional Review Board at the University of Nevada, Las Vegas for the
protection of human subjects.
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Chapter 4 – Results
Question One: General Characteristics of State Reporting Requirements
Of the 52 state-level health departments (states) evaluated, 51 (98%) provided their
reportable conditions in a list format either on the state’s website or in a downloadable
document. The District of Columbia provided a link to the regulations specifying which
conditions must be reported but did not provide a reporter-friendly version of the list of
reportable conditions. It also did not provide the list of reportable conditions as part of the form
provided for disease reporting. While Nevada provided a list of reportable conditions on the state
website, the list was last updated in 2004 and was out-of-date compared to the disease reporting
form (which included a more recent, but still out-of-date, list).
Forty-one states (79%) provided the list in a poster format that could be displayed in the
offices of healthcare providers. Thirty-three states (63%) provided separate lists for both
clinicians and laboratories or indicated specific laboratory reporting requirements within the
same document; the remaining 19 states (37%) had a combined list for all types of reporters but
did not list specific requirements for laboratories. All states except Illinois (98%) made reference
to the specific laws mandating the reporting of disease.
Several states listed the results from a particular test as making a condition reportable; no
state did so throughout their reporting requirements for all conditions, and the test results were
only listed for the occasional condition (for example, a positive PPD test requiring the reporting
of latent tuberculosis). Additionally, no state provided a list of LOINC or SNOMED codes that
indicated which tests necessitated the reporting of conditions through electronic laboratory
reporting. Only Missouri listed the ICD-9 and ICD-10 codes for the conditions reportable by
clinicians for a majority of conditions.
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While 42 states (81%) provided instructions on how reports were to be filed with the
health department, 8 of these states (19%) did not provide forms to be used in the reporting
process. One state, Indiana, provided a form for the reporting of disease but did not describe the
process of submitting the form and provided neither an address nor a fax number. Only 14 states
(27%) described an online method for submitting reports of notifiable conditions.
Over half the states have updated their reportable conditions list within the past two years
and 85% have updated their list within the last five years. Only two states, Kansas and
Minnesota, have not updated their lists within the past eight years. Figure 2 provides the full
distribution of the years since state reportable conditions lists were updated. The majority of
states did not list the date the disease reporting website was last updated, with only 14 (27%)
providing that information. Of the 14 webpages with dates, five (36%) were not listed as being
updated since the date of the last revision of the state’s reportable condition list.
Question One: State Condition Reporting Requirements
Descriptive epidemiology of state reporting requirements
Only one state, Louisiana, required the reporting of all nationally notifiable conditions in
2015. The number of NNCs reportable in each state ranged from 61 to 80 (76% to 100%), with a
mean of 71.8. The distribution of the number of NNCs reportable by states is represented in
Figure 3. Individual state results are presented in Table 1.
Nationally, 86% of reportable NNCs were explicitly reportable in states where they were
required to be reported, 11% were reportable as part of a broader category of conditions (such as
hepatitis C, acute and hepatitis C, past or present both being reported as part of the larger parent
category of hepatitis C), and 3% required a subset of disease to be reported (for example, the
NNC has no age restriction but is only reportable in children in the state).
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States required disease reporting using a total of 28 different timeframes; individual states
used an average of 4 different timeframes (range: 2 to 6). Only three of these timeframes were
used by a majority of states: 43 states (83%) required immediate reporting of some conditions,
42 states (81%) required reporting of cancer within 6 months, and 31 states (60%) required
reporting of numerous conditions within one day. This distribution of disease reporting
timeframes is presented in Figure 4.
The timeframe for the most urgent category of reporting is “immediately” for 42 states
(81%), “2 hours” for one state (2%), “4 hours” for one state (2%) and “1 day” for 8 states (15%).
Twenty-one NNCs (26%) must be urgently reported in the majority of states in which they are
reportable. These conditions are presented in Table 2.
Seventy-two categories of reporters are required to report disease throughout the country.
Laboratories are required to report conditions in all states, and three additional categories of
reporters are required to report conditions in a majority of states; 41 states (79%) require
physicians to report, 29 (56%) require hospitals to report, 28 (54%) require the broad category of
healthcare providers to report, and 21 (40%) require the broad category of healthcare facilities to
report. Fifty-eight of the 72 categories of reporters are required to report in ten or fewer states; 19
categories of reporters (26%) are required to report conditions in only one state, and 20
categories of reporters (28%) are required to report conditions in two states.
Descriptive epidemiology of condition reporting
Twenty-four of 80 NNCs (30%) were explicitly reportable in all 52 state-level
jurisdictions. Ten additional conditions were reportable in all jurisdictions using any reporting
criteria, for a total of 34 NNCs (43%) that were required to be reported in all states. These
conditions are listed in Table 3.
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Fifty-four NNCs (68%) were reportable in at least 90% of states and 69 NNCs (86%)
were reportable in at least 80% of states. Only four conditions (5%) were reportable in fewer
than half the states; these conditions included carbon monoxide poisoning, silicosis,
coccidioidomycosis and nonparalytic poliovirus infections. Thirty-seven conditions (46%) were
explicitly reportable in 90% of states. The complete list of the number of states requiring the
reporting of an NNC by reporting type is provided in Table 20. Information on the reporting
practices for each nationally notifiable condition is provided in Figures 17 through 96 found in
Appendix C: Nationally Notifiable Condition State Reporting Requirements.
For eight NNCs (10%), the majority of states requiring reporting did so as part of a
broader category of disease rather than making the disease explicitly reportable on its own. Six
additional conditions (8%) were reportable as part of a broader category in at least 40% of states.
These conditions are presented in Table 4.
The only NNC for which the majority of states required the reporting of a narrower
category of disease was spotted fever rickettsiosis; 26 of 48 states (54%) that required the
reporting of spotted fever rickettsiosis did so by requiring the reporting of Rocky Mountain
spotted fever rather than broader category. Twenty-two of 49 states (45%) that required the
reporting of Hantavirus infection did so as the narrower condition Hantavirus pulmonary
syndrome. Sixteen of 51 states (31%) did not require the broad reporting of the arboviral disease,
but rather required the reporting of one or more individual arboviral diseases such as West Nile
virus infections or St. Louis encephalitis virus infections.
Descriptive epidemiology of disease reporting by population.
The percent of the United States population for which a disease must be reported was
similar to the percentage of states in which a disease must be reported, with an average
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difference between the two measures of 1%. Fifty-nine NNCs (74%) were reportable in states
covering at least 90% of the United States population and 67 NNCs (84%) were reportable in
states covering at least 90% of the United States population. Three conditions (4%) were
reportable in states covering less than half the United States population; these conditions are
carbon monoxide poisoning, coccidioidomycosis and silicosis.
The average difference between the percentage of states in which an NNC was reportable
and the percentage of population for which an NNC was reportable is 1.1%, with a standard
deviation of 3.9%. Only six conditions (8%) had a difference of greater than two standard
deviations above or below the mean; these conditions are presented in Table 5.
Reporting of non-notifiable conditions
A total of 163 unique conditions not found on the NNC list were reportable in states. This
included chikungunya, which was recommended for addition to the 2015 NNC list but had not
been officially added as had not completed the Office of Management and Budget approval
process. Six conditions not on the NNC list were reportable in a majority of states and are
presented in Table 6. This includes AIDS, which was reclassified on the NNC list as stage III
HIV disease for 2014 but is still listed as a reportable condition in 37 states (71%). Sixty-three
conditions (39%) were only reportable in a single state, 113 (69%) were reportable in five or
fewer states, and 142 (87%) were reportable in ten or fewer states. The distribution of the
number of states requiring the reporting of non-NNCs is presented in Figure 5.
The number of non-NNCs required to be reported in a state ranged from 7 to 39, with an
average of 17.6 conditions. The distribution of the number of non-NNCs reportable in states is
presented in Figure 6.
Reporting of former nationally notifiable conditions
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Between 1951 and 2014, fourteen conditions were removed from the NNC list. Four of
these conditions, pneumonia and three types of post-infection encephalitis, were not reportable in
any state in 2015. Nine former nationally notifiable conditions were still reportable in 2015 in
one or more states, although only one condition, group A streptococcal infection, was reportable
in a majority of states. The required reporting of former NNCs is presented in Table 7. Of note is
that influenza was still required to be reported in 9 states despite being removed from the list in
1951.
State reporting of all conditions
On average, states required 89 conditions to be reported including NNCs and non-NNCs
(average = 89.4, median = 87.0, mode = 85 and SD = 10.2). The distribution of the number of
reportable conditions in states is presented in Figure 7.
Question one summary
States varied widely in the number of conditions required to be reported, and only one
state required the reporting of all nationally notifiable conditions. The null hypothesis that all
state-level public health jurisdictions do not mandate the reporting of all conditions under any
category of reporting on the 2015 nationally notifiable conditions list was supported.
Question Two, Part One: State-Specific Factors
No state factors were found to have a statistically significant association with the number
of nationally notifiable conditions (Table 8), and no state factors had a statistically significant
association with the number of non-nationally notifiable conditions reportable in a state by chisquare testing.
Question two, part one summary
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No state-specific factors were associated with a higher number of nationally notifiable
conditions being reportable in a state. The null hypothesis that no state-specific factors are
associated with a state including a greater than median number of 2015 nationally notifiable
conditions on their respective state’s 2015 reportable conditions list was supported.
Question Two, Part Two: Condition-Related Factors
No condition-specific factors were found to have a statistically significant association
with the number of states in which the nationally notifiable condition was reportable. Pearson Χ2
values and corresponding p-values are presented in Table 9.
Question two, part two summary
No condition-specific factors were associated with a condition being including on a
greater than median number of 2015 state reportable conditions lists, thus the null hypothesis is
supported.
Question Three: Timely Addition of NNCs to State Reportable Lists
Between 1992 and 2012, fifteen conditions were added to the nationally notifiable
conditions list; these conditions and their years of addition are listed in Table 10. For the
purposes of this analysis, the non-communicable/infectious conditions (elevated blood lead,
acute pesticide injury or illness, silicosis and cancer) and waterborne outbreaks were excluded,
as data about the state patterns of addition to their respective reportable lists was unavailable.
National reporting data were available starting the year of addition to the NNC list; data
about state reporting requirements prior to the NNC addition were not available. As a result, it
was not possible to differentiate states that implemented condition reporting in the year of the
NNC addition from those that required reporting prior to the NNC addition.

51

The time difference between the addition of a condition to the nationally notifiable
conditions list and the addition to the state reportable list ranged from zero to fourteen years. A
majority of states made reportable a newly-added nationally notifiable condition for nine of the
ten conditions evaluated within 18 months. Babesiosis was the only exception, and was made
reportable in 48% of states within 18 months. The results for all conditions are presented in
Table 11.
The majority of states that made the condition reportable as of 2015 did so during the
year it was added to the NNC list, and 82% of states that chose to add it did so within the first 18
months after the condition was added to the NNC list. The distributions of the times until state
addition are provided in Figure 8 through Figure 16.
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Question three one summary
A majority of states that added nationally notifiable conditions to their reportable
conditions list within 18 months for all ten conditions evaluated. Additionally, nine of ten
conditions were made reportable within a majority of all states within 18 months; the tenth
condition was made reportable in 48% of states within 18 months. The null hypothesis, that the
majority of state-level public health jurisdictions do not add conditions to their list of statereportable conditions within 18 months after they have been added to the list of nationally
notifiable conditions, is rejected.
Question Four: Compliance with National Reporting Recommendations
Elevated blood lead
Only three states, Hawaii, South Dakota and West Virginia, do not mandate the reporting
of elevated blood lead levels. Of the 49 states that do mandate it, 28 (57%) require reporting of
laboratory results in a manner consistent with the position statement making it nationally
notifiable in 2010 (Stanbury, 2009), which recommends that any blood lead testing result,
regardless of finding, be reported to the health department. The remaining 21 states (43%)
require some form of narrower reporting than the national recommendation. The differences in
reporting requirements are presented in Table 12.
All 49 states that require reporting of elevated blood lead levels require that clinicians
and laboratories report. Additionally, 48 of 49 (98%) states mandate reporting by reporters other
than clinicians and laboratories (beyond the national recommendation). Five states (10%) require
reporting only by one of the entities explicitly listed in the national recommendation (hospitals,
veterinarians, or pharmacies), nine (18%) require reporting only by entities other than those
explicitly listed, and 37 (76%) require reporting by both explicitly-listed and non-listed entities.
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Only one state, Georgia, has required reporting by entities that match the national
recommendation. Georgia also requires the reporting of all blood lead tests in all ages, making it
the only state that fully complies with the national recommendation.
Influenza-associated pediatric mortality
Forty-eight states (Table 13) mandated the reporting of pediatric influenza mortality in
some form. A majority of states, 27 (56%), specifically required the reporting of pediatric
influenza mortality. Twelve states (25%) required influenza mortality reporting of a larger age
group. Only 1 state (2%) required that reporting in a narrower age group. Eight states (17%)
required the reporting of any influenza disease across all age groups, and this presumably
included the reporting of pediatric influenza-associated mortality.
It was not possible to determine if the criteria used by states to require reporting followed
the national recommendations (Gensheimer &Fowlkes 2009) on pediatric influenza-associated
mortality, as no state listed specific requirements for clinical or laboratory criteria that
necessitated reporting of the condition.
Consistent with national recommendations, all states required reporting of pediatric
influenza mortality by laboratories and clinicians. Forty-seven of 48 states (98%) required
reporting by other entities, consistent with recommendations. Only four states (8%) matched the
explicit recommendation of reporting by hospitals, pharmacists or veterinarians. Table 14
provides the state reporting requirements by additional reporters.
Shiga toxin-producing Escherichia coli
Some form of Shiga toxin-producing Escherichia coli (STEC) was reportable in all 52
state-level jurisdictions in 2015. Two states (4%) required reporting of Escherichia coli
O157:H7, a subset of the broader nationally notifiable condition (Dunn & Marder 2013). One
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state (2%) required the reporting of the broader category of Escherichia coli. The national
recommendation included the reporting of persons diagnosed with post-diarrheal hemolytic
uremic syndrome; 50 of 52 (96%) state-level jurisdictions mandated reporting of this condition.
Additionally the national recommendation included the reporting of persons who have a positive
culture for of Escherichia coli O157:H7; 30 states (58%) had such a requirement.
The national recommendation included reporting by clinicians, laboratories and other
entities (poison control centers, hospitals, veterinarians, and pharmacists). Five states (10%) fully
followed this recommendation. Table 15 provides the state reporting requirements by additional
reporters.
Tuberculosis
Tuberculosis (TB) was reportable in all 52 state-level jurisdictions in 2015. As presented
in Table 16, states took different approaches to TB reporting. Eight states (15%) required the
reporting of latent TB infection in addition to active TB cases. Latent TB infection was not
recommended to be part of states reporting requirements in the national recommendations
(Montero, Hull, Lynch, & Parrish 2009). Also as described in Table 16 are TB-specific reporting
requirements for pharmacists, which were required in 13 states (25%).
The national recommendation includes reporting by clinicians, laboratories and other
entities (poison control centers, hospitals, veterinarians, and pharmacists). Five states (10%) fully
followed this recommendation. Table 17 provides the state reporting requirements by additional
reporters, which is identical to the requirements for Shiga-toxin producing Escherichia coli.
Question four summary
There was little consistency between the states or the conditions evaluated for this
research question. Some states had reporting requirements beyond the national
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recommendations, and others had a more restricted set of requirements than the national
recommendations. As such, the null hypothesis that reporting jurisdictions mandate the reporting
of conditions on the nationally notifiable conditions list utilizing the same reporting criteria as in
the recommendation was rejected.
Summary
State reporting practices varied widely in terms of what was reportable, who was required
to report, and the timeframe in which the report must be submitted, supporting the null
hypothesis that all state-level public health jurisdictions do not mandate the reporting of all
conditions in 2015.
Two state-specific factors associated with a higher number of nationally notifiable
conditions being reportable in a state were identified, rejecting the null hypothesis that no statespecific factors are associated with a state including a greater than median number of 2015
nationally notifiable conditions on their respective state’s 2015 reportable conditions.
No condition-specific factors were associated with a condition being including on a
greater than median number of 2015 state reportable conditions lists, supporting the null
hypothesis that one or more condition-specific factors are associated with a condition being
including on a greater than median number of 2015 state reportable conditions lists.
A majority of states add nationally notifiable conditions to their reportable conditions list
within 18 months for all ten conditions evaluated rejecting the null hypothesis that state-level
public health jurisdictions do not add conditions to their list of state-reportable conditions within
18 months after they have been added to the list of nationally notifiable conditions, is rejected.
Finally, states were inconsistent in their implementation of the national reporting
recommendations, rejecting the null hypothesis that reporting jurisdictions mandate the reporting
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of conditions on the nationally notifiable conditions list utilizing the same criteria set forth in
national recommendations.
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Chapter 5 – Discussion
Summary of the Study
Differences in state condition reporting have not been previously well described, and the
limitations due to these differences are often overlooked both in the popular press and in
scientific studies. This study sought to understand these differences and elucidate the factors that
lead to the interstate differences in condition reporting. To do so, this study addressed the
following questions:
1. Do all states require the reporting of all conditions on the 2015 nationally notifiable
conditions list?
2. What state-specific factors are associated with a state including a large number of
these conditions on their reportable conditions list?
3. What condition-specific factors are associated with a condition being included on a
large number of state reportable conditions lists?
4. Do states quickly add conditions to their state reportable lists when they are added to
the nationally notifiable conditions list?
5. Do states follow national recommendations as to the reporting criteria that are
implemented?
Widely-varying implementations of disease reporting between the state-level jurisdictions
were identified in this study, and no factors adequately explained these differences. While larger
states were more likely to require that a greater number of diseases be reported, there was no
linear relationship between population size and the number of reportable conditions.
The most important finding of this study is that the nationally notifiable conditions list is
largely a reflection of what is reportable in states and does not really set national priorities.
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Adding a condition to the nationally notifiable conditions list does not necessarily lead to states
making that condition reportable, and conditions that are reportable in states follow the historical
implementation of disease reporting in the state and not national recommendations.
The individual state differences are important to consider when evaluating national
disease statistics, as differences in how the data are collected can lead to widely varying reported
incidence, even if states have the same true incidence. The fact that such differences exist despite
the existence of national disease reporting recommendations creates a large hurdle to overcome
to make automated disease reporting from electronic health records a reality.
In general, individual state-level health departments have implemented widely varying
approaches to all aspects of the mandatory reporting of disease within their jurisdictions. The
reportable conditions, the reporter types, and the timeframes in which reports were required to be
submitted differed considerably. With the exception of Nevada, state health department websites
were up to date and generally provided the information clinicians needed to report a condition.
States did not provide the codes needed to implement the automated reporting of disease
from electronic health records or through electronic laboratory reporting on their websites. Only
one state, Missouri, provided the ICD-9 and ICD-10 codes for a majority (but not all) of their
reportable conditions. This is a severe limitation of NNDSS, as these codes are necessary to
ensure prompt and complete reporting of laboratory results and diagnoses.
A proposed solution to the lack of codes was the creation of the “Reportable Conditions
Mapping Table”, a list of Logical Observation Identifiers Names and Codes (LOINC) codes used
to classify laboratory results (Centers for Disease Control and Prevention, 2012). This solution
has major limitations, as it is described as standardizing “reportable lab result reporting to public
health”, but only contains nationally notifiable conditions and does not include the many non-
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nationally notifiable conditions reportable in states that were identified in this study. As the legal
foundation of disease reporting is based in state laws, the list is not usable without all staterequired conditions, and its utility is limited to use for electronic laboratory reporting as it does
not contain reportable diagnosis codes.
An added layer of complexity in developing an ontology for condition reporting is that
11% of conditions reportable to state-level health departments are done so under a broader parent
category. In order for the ontology to accurately reflect the reporting requirement of the states, it
would have to include the relationships between conditions and the broader reporting category
by which they are reported. This may be straightforward for a condition such as acute hepatitis B
being reported under the broad category of hepatitis B, but this ontology would be very complex
if had it to include broad categories such as occupational disease or unusual occurrences of
illness.
The 28 different reporting timeframes used in states are an unnecessary complexity due
to having no national standards for general condition reporting. The purpose of the timeframes
can be inferred from the notification timeframes used by CDC: immediate, urgent, and routine
(plus a special category for cancer reporting). This is consistent with the finding that states use,
on average, four different reporting timeframes.
Of even greater complexity are the 72 different reporter types that are required to report
conditions in different states. Many of these reporter types are non-medical, such as food
facilities, camps or parole officers, and would be relying on the clinical or laboratory diagnosis
of another required reporter. Similarly, many of the required medial reporter types would not be
involved in a primary diagnosis, such as a contact lens distributor, dietitian or occupational
therapist. Many of these reporter types were included in state regulations because the regulations
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broadly require medical professionals licensed in the state under the purview of a particular
licensing authority to report.
Over half of the identified reporter types are only required to report in one or two states,
which calls into question the utility of including these reporter types. This is consistent with the
standard template for adding a condition to the nationally notifiable conditions list which
specifically mentions only six reporter types as sources for case ascertainment: clinicians,
laboratories, and other entities (e.g. hospitals, veterinarians, pharmacies, and poison control
centers) (Council of State and Territorial Epidemiologists 2015).
There are several approaches to resolving the problem of interstate differences in disease
reporting. Conceptually, the simplest approach is to create a federal mandate for disease
reporting to be followed by all states. This is not feasible, as it would require a constitutional
amendment to give this power to the federal government. However, this did not prevent
(ultimately unsuccessful) attempts to put the system under federal control. Under the guise of
bioterrorism preparedness, Nebraska senator Chuck Hagel introduced the National Reportable
Conditions Act in 2006, which would have created a second list of nationally notifiable
conditions and established the National Reportable Conditions System, a system to report these
conditions to the Department of Homeland Security (S. 3898, 2006). The bill was not passed out
of committee. It was reintroduced two years later as the National Integrated Public Health
Surveillance Systems and Reportable Conditions Act, which removed the reporting provisions
and replaced them with a request for additional funding of the existing system (S. 3476, 2008).
As with the previous bill, it did not pass out of committee, indicating that congress was not
interested in taking up this issue.
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A second approach would be for the states to voluntarily agree to use the same list of
reportable conditions, reporter types and timeframes. This approach would not face the same
constitutional issues as a top-down, federally-mandated approach, as it would be under the
control of the states. In order to be successful, this project would require a governance structure,
funding, and a commitment from states to not continue to create their own version of the central
system; this would be similar to the challenges of managing an open-source software
development effort. However, states have always had this option and have not chosen to
standardize any parts of the reporting process other than case definitions, as is evident from this
study. The result of this approach is the dysfunctional system currently in place, and it is unlikely
to change.
The approach most likely to succeed would the approach the federal government has
taken to implementing issues in transportation, namely a consistent blood alcohol content level
for drunk driving across all states. States were not mandated by congress to establish a .08 blood
alcohol content level for drunk driving; however, congress used the leverage of withholding
federal highway funding as a way to coerce states to follow their wishes. This action was found
to be a constitutional use of the commerce clause of the United States Constitution in South
Dakota v. Dole (1987).
This approach could be particularly effective in public health, where federal funding
makes up a majority of most states’ public health budget. In fiscal year 2013, states spent $11.1
billion to fund public health activities, while federal funding distributed to states from CDC and
the Health Resources and Services Administration totaled $12.8 billion (Levi & Segal, 2014).
Funding is provided in the form of cooperative agreements (non-competitive, often population-
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based allotments) and competitive grants, and could be used as leverage to push states toward
adopting national standards.
The commerce clause has often been used to allow the involvement of the federal
government in issues which for which it has not been given explicit power in the United States
Constitution. Whether withholding cooperative funding is allowed under the commerce clause
would be an issue for constitutional lawyers to decide, but there should be no issue in the
inclusion of such a requirement in grants issued by the CDC, as the numerous requirements of
existing grants have not been acceptable to states.
In order to implement a comprehensive change to standardize the system across the
states, I propose a complete overhaul of state disease reporting and national notification. There
are several steps to this proposal:
1. Establish an independent organization to manage the system and serve as the national
standards developing organization (SDO).
2. Develop the standards which will be implemented in all reporting jurisdictions, at the
state, local and territorial levels.
3. Modify state laws to incorporate the newly-developed standards.
4. Require that states follow the standards in order to be eligible for CDC grant funding.
The first step, the establishment of the SDO, is necessary as there is no organization that
represents all partners on an equal basis. The focus of the project, and disease reporting in most
discussions, is at the state level. However, state laws often make the local health departments
responsible for the management of the system and place the state in the role of simply
aggregating data from the local health departments. This is the case in Nevada, where county
health departments are given broad authority to prevent and control disease (Nevada Revised
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Statutes 439: Administration of Public Health, 2013), and are required simply to inform the
state’s Chief Medical Officer of the number of identified cases or suspected cases on a weekly
basis (Nevada Revised Statutes 441a.170: Weekly reports to Chief Medical Officer, 2013). Also,
as described earlier, some local health departments have the legal authority to mandate the
reporting of conditions of local concern.
In order to establish an SDO that equally represents these different sectors of the diseasereporting continuum, a new organization would have to be created, as existing organizations only
represent individual levels of disease reporting, such as local health departments or state health
departments. It would also be important to include representatives of clinicians, laboratories and
other reporter types, as the practical concerns of disease reporting and the burden it places on
reporters would also have to be considered.
The major barrier to the first step would be the funding of such an organization.
However, if this organization is the result of a federal push for standardization, the CDC would
ultimately be responsible for the financial support of the organization.
The second step in implementing a solution would be the development of a formal
standard for disease reporting. A form of this process already exists through CSTE position
statements and the development of disease-specific standards at CDC. These process would be
merged into a community-driven process through the SDO, and would result in a clear,
comprehensive standard that could be applied at all levels of disease reporting. It would define
which conditions are nationally notifiable, the case definitions for all conditions of interest to
public health, the reporter types required to submit reports, the timeframes in which they must be
submitted, the data that must be included in the initial report submission, and the technical
process that is used for condition report submission. Additionally, the data elements included in
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the reporting and notification of the condition would be included, which, unlike the current
process, would allow for the participation of the groups that generate the data (e.g., clinicians
and laboratories) and those that collect the data (e.g., county and city health department).
The major barrier to the second step would be differing opinions on what should be
included in the standard. This is not an uncommon problem for any SDO, and the SDO can be
structured to deal with these issues. This SDO could be modeled after other community-based
SDOs such as Health Level 7 (HL7), which develops standards through a democratic process of
ballot proposals and member voting.
The third step in the process would the modification of state, territorial, and local
regulations to use the newly-developed national standards. While this process is easy to describe
conceptually, it will be difficult to implement as it requires understanding the laws of each
reporting jurisdiction in the country. This process will be different for each reporting jurisdiction;
in some cases, these changes will require legislative action, and in others it will be a rulemaking
process that falls under the state health department. As a result, while states can learn from the
successes and failures of other states, a single, effective approach cannot be develop that will
work across all jurisdictions.
There are two barriers to this step of the process. First, there are fiscal challenges in
hiring additional staff to evaluate existing legislation and craft appropriate modification of the
state laws. CDC could provide direct financial support to states as part of existing funding
streams such as the Public Health Emergency Preparedness cooperative agreement or the
Epidemiology and Laboratory Capacity grant program. This could overcome state objections to
the expense of such a project. The second barrier is political, as this requires working through a
political process to change legislation, and varies by state. The CDC could play a role in assisting
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health departments, helping to prepare state health officials for legislative testimony or testifying
directly to legislative committees on the need for such a system.
The final step in implementation is requiring that states follow the national standard to be
eligible for federal public health funding. While it would be unethical to withhold funding to pay
for the vaccination of low-income children, it would be reasonable to withhold funding for
surveillance and investigation activities if states do not choose to follow the national standards.
The barrier to this step would be political, for example, pressure on CDC from a highlyranking member of the Senate finance committee from a state that does not want to follow the
national standard. This political pushback would be unlikely to occur at this point, as the states
would have been involved in the process of developing the standards and have been supported by
CDC and other states in the modification of their regulations.
In summary, the development and implementation of a national reporting standard is
feasible through a well-planned, inclusive, financially-supported process. If states are given time
to comply and the support to do so, a national standard of disease reporting could become a
reality. The requirement that states use national standards in their reporting process to be eligible
for CDC grants would provide the incentive to participate in the process, and would ensure that
all states do so in a reasonable timeframe.
Research Question One Discussion
Despite the recommendation in the position statement that made each condition
nationally notifiable by a majority vote of states that “all States and Territories enact laws (statue
or rule/regulation as appropriate) to make this disease or condition reportable in their
jurisdiction” (Council of State and Territorial Epidemiologists, 2015), some states have chosen
not to follow this advice for a majority of nationally notifiable conditions.
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Only 30% of all conditions were explicitly reportable in all states, and 43% of nationally
notifiable conditions are reportable in all states if the other categories of disease reporting
(broader and narrower) were included. Only two-thirds of conditions were reportable in at least
90% of states, and only one state was found to require that all NNCs be reported. The findings of
this study are consistent with the evaluation of the 2008 State Reportable Conditions Assessment
(SRCA) that found that two-thirds of nationally notifiable conditions were explicitly reportable
in over 90% of states (Jajosky et al. 2011).
Incorrect reporting of which diseases are reportable to the CDC by listing a condition as
reportable when it is not (through the SRCA and by submitting disease notifications weekly)
presents an issue affecting national disease rates. For example, New Mexico routinely reports
pertussis cases to CDC through the NNDSS and listed it as being reportable on the SRCA despite
not being listed as a reportable disease in their disease charts or state regulations. If it is required
to be reported because it is a “condition dangerous to public health or safety” (New Mexico
Administrative Code 7.4.3.7, 2012) but is not dangerous enough to include as explicitly
reportable despite it occurring every year and requiring a public health response, then it raises the
question of why New Mexico conducts surveillance on the condition at all. The result of states
identifying a condition as reportable when it is not is an underestimation of the national rates, as
the states contribute fully to the population denominator but partially or not at all to the
numerator (number of cases).
Differences in the implementation of condition reporting at the state and local level raise
a question about the process of making a condition nationally notifiable: do states make a disease
reportable because it is nationally notifiable, or do states make it nationally notifiable because it
is reportable in a majority of states?
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For the conditions evaluated in this analysis, an average of 34 states required the
reporting of a condition in the year it was added to the nationally notifiable conditions list. An
average of 3 states added the condition to the state’s reportable condition list the year after it was
added, and an average of 8 states added it at a later time. This would indicate that the state
reporting practices drive the inclusion of conditions on the NNC list, rather than the NNC list
driving state reporting practices.
Examples of this can be found in the position statements that have added conditions to
the NNC list. In adding giardiasis to the NNC list, Gibson and Ball noted that “Less than 10
states will need to establish Giardiasis as a reportable condition” (2001). When
campylobacteriosis was added to the list, it was noted that 49 states and territories already
mandated reporting (Bradlek, DeMaria Jr, & Geissler, 2014). The addition of cancer to the NNC
list was justified in part because “all states have a cancer registry that is statewide and
population-based” (Hylton & Huang, 2009). Nineteen states reported an explicit reporting
requirement and sixteen states reported an implicit requirement on the 2010 SRCA (Council of
State and Territorial Epidemiologists, 2011); 24 states notified CDC of cases of babesiosis the
first year it was nationally notifiable.
There is no official position by the nation’s epidemiologists that states that the state rules
drive the placement of a condition on the NNC list. In 2008 CSTE passed a position statement
that required that a condition be reportable in half the states or states comprising 50% or more of
the United States population before it could be added to the NNC list (Engel 2008). However,
this requirement was removed two years later over concerns about the inability to add emergent
conditions to the list (Rolfs & Smith 2010). Based on this series of events, it can be inferred that
adding emergent conditions to the NNC list can drive states to adopt reporting, but routine
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conditions (the bulk of those added to the nationally notifiable list) are added to the nationally
notifiable conditions list only when they are reportable in a number of states. No emergent
conditions have been added to the NNC list since 2010, so this cannot be evaluated.
State reporting practices driving the nationally notifiable conditions list is consistent with
supporting the null hypothesis that all state-level public health jurisdictions do not mandate the
reporting of all conditions on the 2015 nationally notifiable conditions list. In general, if states
did not require that a particular condition be reported before it was added to the nationally
notifiable conditions list, it is unlikely that they will take swift action to make it reportable once
it is added to the national list.
Research question two, part one: what state-specific factors, if any, are associated with a
state including a greater than median number of 2015 nationally notifiable conditions on their
respective state’s 2015 reportable conditions list?
Research Question Two, Part One Discussion
Total CDC funding and state population were both identified as having a statistically
significant association with the number of nationally notifiable conditions reportable in the states
when grouped into a dichotomous high/low category and led to a rejection of the null hypothesis
that no factors were associated with a state including a greater than median number of 2015
nationally notifiable conditions on their respective state’s 2015 reportable conditions list.
However, neither factor was statistically significant when evaluated for a linear relationship
between the level of funding and the number of reportable conditions. Additionally, both factors
were strongly correlated with each other; unsurprisingly, states with a large population receive
large amounts of CDC funding.
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This finding may be due to the way in which states are funded for public health programs
by the CDC. Many CDC sources of funding are distributed based on state population with larger
states receiving more money. The funding would allow larger states to hire staff to develop
specific surveillance programs and work on specific projects, including surveillance for
particular conditions. These additional programs may drive state decisions to add nationally
notifiable conditions to their reportable conditions list. This evaluation was beyond the scope of
this project, and would require a detailed analysis of CDC grant funding to each state over time
as well as the grant deliverables for multiple grant-funded programs.
Research Question Two, Part Two Discussion
No condition-specific factors were identified as being associated with being included on
state reportable conditions list. This is not surprising, given the identification in question one of
state reportable lists driving the nationally notifiable list. Four of the factors that were evaluated
are classifications that are used by CDC, and if states are driving what is nationally notifiable,
those classifications would not play a role in state decisions to make a disease reportable. A
number of the conditions that are vaccine preventable (the fifth factor evaluated) have been on
the nationally notifiable conditions list since its inception in 1951 (Dauer, 1952) and are
reportable in all states. Varicella is the only exception, and was reportable in over 80% of states.
The high level of reporting for vaccine-preventable conditions makes a statistical comparison
impossible, as there is no group against which comparisons could be made.
Research Question Three Discussion
Although it was found that a majority of states do add conditions to their reportable lists
within 18 months of their addition to the NNC list, this may be misleading. Data are available
about which conditions were reportable in each state starting the year of addition to the NNC, but
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state reporting requirements prior to those years could not be analyzed. Given that state
reportable condition requirements appear to drive the NNC list additions, it is likely that the
states were not adding the condition quickly after it was added to the list, but that they were
reporting data to CDC for conditions that were already reportable in the state.
At first glance, babesiosis appears to be an outlier, with only 24 states requiring the
reporting of the condition in 2011, the year it was added. As the disease is transmitted by the
same tick that causes Lyme disease, the states that routinely identify cases of Lyme disease were
the states that made it reportable. Of the 15 states with the highest reported cases of Lyme
disease in 2012, 13 required the reporting of babesiosis (Adams et. al, 2014). babesiosis can be
thought of as an extension of Lyme disease reporting, and is consistent with the idea that state
reportable conditions drive the nationally notifiable conditions list. As described earlier,
babesiosis was explicitly reportable in nineteen states on the 2010 SRCA, which was conducted
before babesiosis was added to the NNC list (Council of State and Territorial Epidemiologists,
2011).
Research Question Four Discussion
For three of the four conditions evaluated, elevated blood lead, influenza-associated
pediatric mortality and Shiga toxin-producing Escherichia coli, laboratory testing is a necessary
part of disease reporting (i.e. a report cannot be filed without laboratory evidence). As a result,
including a number of additional reporting entities would likely not increase the reporting rate of
disease, as the laboratories (which are required to report in all 52 state-level jurisdictions) are the
true source of information. Point-of-care testing for blood lead is the one exception, although
clinicians performing such a test are required to report as if they were a laboratory in many
states.
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For tuberculosis, laboratory testing is necessary for confirmation and classification of the
case, but states typically require that the condition be reported based on clinical presentation
alone, as laboratory testing can take weeks to months to complete. Reporting by pharmacists of
patients who have been prescribed antibiotics typically used for the treatment of tuberculosis
may increase early case finding and help public health officials take early action, but will not
affect overall disease reporting, as the laboratory will eventually report positive cases.
The diversity of disease reporting requirements in states, coupled with minimal
information contained in laboratory reporting requirements in each state, made the analysis of
this research question difficult. However, this is consistent with states driving additions to the
nationally notifiable conditions list. If states have already made the disease reportable when it is
added to the nationally notifiable conditions list, there is little incentive to modify the state
reporting laws to match recommendations that are not legally binding.
Implications
The most important implication of this study is that the data presented as describing the
incidence or prevalence of disease in the United States is collected in an inconsistent manner to
the extent that it may be unreliable or subject to manipulation by states, especially if funding is
tied to the incidence or prevalence of disease. If data are collected in an inconsistent manner
from state to state, the results will not be comparable even if identical case definitions are used.
The case definition can be thought of as a filter, only allowing certain types of cases to flow
through. However, if the volume of reports being filtered in two states differs because the laws of
one state result in a greater percentage of cases being reported, one state would have a higher rate
of reported disease even with the same underlying true rate of disease.
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Another implication of this study derives from the identification that states are largely
driving what is placed in the nationally notifiable conditions list rather than being driven to make
nationally notifiable conditions reportable within their jurisdictions. As a result, the national
standards are based on what was developed in an isolated, parallel fashion in multiple states.
This also makes states less likely to change their reporting rules to match a national standard.
Any attempts to standardize disease reporting across the states would be extraordinarily difficult,
as there is no lead agency that the states would follow.
These intrastate differences could create significant barriers to the electronic reporting of
disease from electronic health records (EHR), as systems would have to be developed that were
unique to each reporting jurisdiction. EHR vendors are likely to be unwilling to customize the
disease reporting to match the peculiarities of disease reporting in the over 3,000 local health
departments in the United States. The result will either be an unwillingness to provide any
electronic reporting of disease or forcing the health departments to use a standard, vendordeveloped system that does not meet the needs of the health departments.
The findings of this study also have implications for the Reportable Conditions
Knowledge Management System (RCKMS), which has been endeavoring to create a central
electronic database of reporting requirements that is usable both by humans and machines
(Altamore, Conn, Staes, & McGarvey, 2013). Most recently, the RCKMS has piloted the
development of a set of standardized reporting criteria among several states and local health
departments. While the development of such a standard would be beneficial to public health, it
would require states to change their laws in order to implement it. While Altamore, Smithee,
Vahora, & Arnold concluded that “Providing -- and maintaining -- a single, comprehensive,
authoritative, real-time portal to reportable conditions information presents substantial
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challenges, to which the public health community” (2015), they focused only on the technical
aspects of such a project. The actual implementation of such a system, even if the technical
aspects are resolved, would be much more complex due to the fact that states are driving the
national standards while simultaneously failing to follow those standards.
Limitations
This study focused on the 52 state-level reporting jurisdictions and not the over 3,000
local health departments. Large counties and cities such as Los Angeles, Las Vegas (Clark
County) and Chicago have considerable public health capacity and may provide better-designed
or more complete reporting information to clinicians and laboratories required to provide the
reports. The evaluation of local disease reporting processes and requirements was beyond the
scope of this study.
The most significant limitation in this study was the limited information provided in the
reporting regulations for each state. While states included the names of conditions that were
reportable, they generally did not provide any additional criteria that necessitated a report being
submitted to the local or state health department.
This issue is rooted in the way state regulations are written, as they are generally crafted
to broadly require the reporting of disease without limitation. For example, Nevada statute
required that health care providers report a condition if it a healthcare provider determines that
the person had a reportable condition based on “Clinical signs and symptoms consistent with the
communicable disease” (Nevada Administrative Code Chapter 441A.180, 2011). No further
description of the clinical signs or symptoms was given in the regulations, leaving it up to the
discretion of the clinician.
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The issue of interpretation of what is reportable by a clinician is not a new issue, as it was
a concern with the first clinician reporting system developed in in 1875. The solution today is no
different today than was described 140 years ago:
For this diversity there is no radical remedy. It is the source of a considerable margin of
error in the registration of mortality, affecting the causes of death; it is the possible origin
of a still wider range of uncertainty in the results of any scheme for registering diseases
which do not afford, in their fatal termination, an additional indication for diagnosis. Our
chief safe-guard is again to be found in the known skill and reputation of the observers.
(State Board of Health of Massachusetts, 1875, p. 481)
The same issue of limited explanation of what is reportable exists for laboratories, as
states do not provide a list of laboratory tests that require submission to the health department. In
Nevada, laboratories must report to the health department findings “in which a test or
examination of any specimen derived from the human body yields evidence suggesting the
presence of a communicable disease, a causative agent of a communicable disease or an immune
response to a causative agent of a communicable disease” (Nevada Administrative Code Chapter
441A.235, 2011). All changes to disease reporting regulations must go through a process that
involves drafting by the Legislative Council Bureau, public hearings, approval by the State
Board of Health, and finally approval by the a committee comprised of the governor, secretary of
state and the attorney general. The length of this process makes it impractical to list specific
laboratory tests in regulation, as newly-approved tests would potentially not be added for years.
An additional limitation is the variation between states in how reportable conditions are
presented to clinicians, laboratories, and other entities required to submit reports. The lists
typically presented to reporters do not contain all condition reporting requirements listed in state
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statute and regulations. They are not presented in a consistent format and may use multiple terms
to describe conditions (for example, using the term “leprosy” to describe Hansen’s disease).
Another limitation is the lack of data on state reporting requirements in the years prior to
a condition’s addition to the nationally notifiable conditions list. If state reporting practices are
driving the additions to the list, it would be possible to see this in the state reporting
requirements. Data on the history of each state’s reporting practices and changes to the list may
be available for recent years, but identifying those changes before the internet was used to
distribute the lists would require identifying and reviewing printed materials from each health
department, assuming such materials still existed.
A final limitation is the inclusion on state reportable lists of the category of “unusual
disease” reporting. While this category serves a necessary purpose of mandating the reporting of
newly emerging or rare conditions in a jurisdiction, it is often used as a catch-all category for
anything that has not been added to the state’s list. The use of such a broad catch-all category to
mandate the reporting of nationally notifiable conditions by clinicians rather than specifically
listing the known reportable conditions would result in misleading results for this study, but
more importantly, potential underreporting on the part of laboratories and clinical providers.
Future research
There has been little research conducted in this area, with most focusing on improving
the completeness and timeliness of disease reporting from laboratories and clinicians to the local
health department. Future research can be grouped into two broad areas: further explorations of
the Nationally Notifiable Diseases Surveillance System and development of standard methods of
disease reporting and notifications.
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While additional study of the Nationally Notifiable Diseases Surveillance System could
explain particular aspects of system differences in more depth, it is unlikely to provide a practical
benefit, as additional cataloging of the dysfunction and variability in the NNDSS would do little
to resolve those issues. Of benefit would be an in-depth analysis of the role of implicit report
disease reporting in states, covering both the general categories such as vector-borne disease and
the broad public health reporting mandate of unusual illnesses.
This research would serve two purposes. First, it would explain how states use broad
categories to potentially simplify the disease reporting process for humans and highlight the
impact of such simplification on the development of electronic reporting systems. It would also
better describe the types of information that would need to be included in a centralized system
for disease reporting (such as the Reportable Conditions Knowledge Management System) in
order to make algorithmic decisions about the reporting of a potential case to public health.
Second, it would describe how the states are using the category of unusual illness within
their jurisdiction. While such a category is necessary so that public health officials can identify
and respond to newly emerging disease threats, it can be misused in order to make routine issues
reportable within the state (as was the example of Pertussis in New Mexico described earlier).
This research would have implications for the political factors involved in the implementation of
a centralized reporting system.
A second area of research is in the development of systems that could be used to
standardize disease reporting across all jurisdictions. While some study has been conducted in
this area, it has been generally limited to specific implementations of a system such as the
Reportable Conditions Knowledge Management System, rather than in a deep understanding of
the factors, both technical and political, on which the success of the system would hinge.
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Conclusion
Data collected through the Nationally Notifiable Diseases Surveillance System is used for
a variety of practical applications throughout public health and is often treated as if it is a
standardized system with reliable, comparable data across all states. In reality, differences
between state reporting processes make it difficult to reliably compare data across states, as each
states is in essence using different inclusion criteria for each disease. State reporting
requirements varied widely on what is reportable, which entities must report, and the timeframes
in which a condition must be reported. This variability is not reflected in national statistics,
where state differences are ignored and conditions are treated as if they are the same from state
to state.
This variability is driven by the process that creates the nationally notifiable conditions
list, as conditions are typically added to the list only after a large number of states have already
chosen to make the condition reportable. As there is no national standard to follow during the
development of the state reporting requirements, states develop their reporting requirements
based on the nuances of the existing individual state reporting process and regulations. The end
result is that when a condition is added to the nationally notifiable conditions list, it is done so as
a hybrid of the many state reporting requirements (which do not reflect the actual practices of
any one state), and states typically do not change their reporting requirements to match this new
standard.
While the Nationally Notifiable Diseases Surveillance System provides flexibility for the
states to only include conditions that are of importance to the state or are within the capacity of
the state to investigate and respond to, it also allows states to develop reporting requirements that
vary widely from other states. This variability must be eliminated if a standardized reporting
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process is to be adopted to allow for electronic reporting of disease to public health authorities in
the United States.
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Appendix A: Figures

Figure 1. United States Department of Health and Human Services human subject
regulations decision chart 1, emphasis added (US Department of Health and Human
Services, 2004)
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Figure 2. Years since state reportable list was updated (as of June 1, 2015) (N=52)

81

Figure 3. Distribution of the number of states requiring the reporting of Nationally
Notifiable Conditions (N=52)
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Figure 4. Number of states requiring disease reporting within a given timeframe (N=52)
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Figure 5. Number of states requiring the reporting of a condition not on the nationally
notifiable conditions list (N=52)
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Figure 6. The distribution of states requiring a number of non-NNCs to be reported (N=52)
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Figure 7. Distribution of the number of conditions required to be reported in states (N=52)
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Figure 8. Years from addition of babesiosis to the NNC and addition to state reportable
lists (N=33)
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Figure 9. Years from addition of cyclosporiasis to the NNC and addition to state reportable
lists (N=44)
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Figure 10. Years from addition of Escherichia coli O157:H7 to the NNC and addition to
state reportable lists (N=52)
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Figure 11. Years from addition of giardiasis to the NNC and addition to state reportable
lists (N=48)
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Figure 12. Years from addition of Q fever to the NNC and addition to state reportable lists
(N=50)
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Figure 13. Years from addition of Streptococcus pneumoniae, invasive, less than 5 years of
age to the NNC and addition to state reportable lists (N=46)
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Figure 14. Years from addition of Streptococcus pneumoniae, invasive to the NNC and
addition to state reportable lists (N=44)
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Figure 15. Years from addition of varicella, invasive to the NNC and addition to state
reportable lists (N=42)
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Figure 16. Years from addition of vibriosis, invasive to the NNC and addition to state
reportable lists (N=44)
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Appendix B: Tables
Table 1. Number of conditions reportable in each state by reporting type (N=80)
Explicitly
Reportable
63

Broadly
Reportable
4

Narrowly
Reportable
0

Any
Reportable
67

Not
Reportable
13

Alaska

54

14

2

70

10

Arizona

64

8

3

75

5

Arkansas

63

13

1

77

3

California

65

9

2

76

4

Colorado

49

11

4

64

16

Connecticut

61

4

3

68

12

Delaware

65

11

1

77

3

District of Columbia

53

12

5

70

10

Florida

65

9

2

76

4

Georgia

58

11

3

72

8

Hawaii

56

6

3

65

15

Idaho

48

11

4

63

17

Illinois

60

8

3

71

9

Indiana

61

5

3

69

11

Iowa

53

12

1

66

14

Kansas

59

9

3

71

9

Kentucky

56

5

0

61

19

Louisiana

73

6

1

80

0

Maine

64

3

3

70

10

Maryland

64

9

3

76

4

Massachusetts

60

14

2

76

4

Michigan

70

6

0

76

4

Minnesota

60

15

0

75

5

Mississippi

58

6

3

67

13

Missouri

73

0

4

77

3

Montana

67

7

1

75

5

Nebraska

64

7

3

74

6

Nevada

57

13

3

73

7

New Hampshire

55

9

1

65

15

New Jersey

69

2

3

74

6

New Mexico

64

5

3

72

8

New York

64

5

3

72

8

New York City

64

5

3

72

8

North Carolina

63

4

3

70

10

North Dakota

52

17

1

70

10

Ohio

67

8

0

75

5

State
Alabama

96

Oklahoma

54

6

4

64

16

Oregon

56

11

0

67

13

Pennsylvania

54

14

2

70

10

Rhode Island

59

10

5

74

6

South Carolina

64

7

3

74

6

South Dakota

67

3

3

73

7

Tennessee

66

4

4

74

6

Texas

65

5

1

71

9

Utah

72

5

1

78

2

Vermont

60

13

0

73

7

Virginia

67

4

4

75

5

Washington

60

3

4

67

13

West Virginia

69

1

3

73

7

Wisconsin

62

13

0

75

5

Wyoming

60

13

3

76

4

97

Table 2. Number of states requiring the reporting of an NNC by reporting requirement
type (N=52)
Nationally Notifiable
Condition
Anaplasmosis

Explicitly
Reportable
35

Broadly
Reportable
1

Narrowly
Reportable
0

Any
Reportable
36

Not
Reportable
16

Anthrax

52

0

0

52

0

Arboviral diseases

35

0

17

52

0

Babesiosis

32

0

0

32

20

Botulism

52

0

0

52

0

Brucellosis

52

0

0

52

0

Campylobacteriosis

51

0

0

51

1

Cancer

52

0

0

52

0

Carbon monoxide poisoning

11

2

0

13

39

Chancroid

45

0

0

45

7

Chlamydia
trachomatis infection
Cholera

48

0

4

52

0

52

0

0

52

0

Coccidioidomycosis

20

0

0

20

32

Congenital syphilis

26

26

0

52

0

Cryptosporidiosis

52

0

0

52

0

Cyclosporiasis

44

0

0

44

8

Dengue virus infections

32

11

7

50

2

Diphtheria

52

0

0

52

0

Ehrlichiosis

43

1

0

44

8

Foodborne disease outbreak

29

22

1

52

0

Giardiasis

44

0

0

44

8

Gonorrhea

52

0

0

52

0

Haemophilus influenzae,
invasive disease
Hansen's disease

48

0

4

52

0

43

2

0

45

7

Hantavirus infection

27

0

22

49

3

Hantavirus pulmonary
syndrome
Hepatitis A, acute

25

24

0

49

3

50

2

0

52

0

Hepatitis B, acute

25

27

0

52

0

Hepatitis B, chronic

20

26

5

51

1

Hepatitis B, perinatal infection

17

31

1

49

3

Hepatitis C, acute

26

25

0

51

1

Hepatitis C, past or present

18

24

1

43

9

HIV Infection

52

0

0

52

0

HUS, post-diarrheal

18

31

1

50

2

Influenza pediatric mortality

27

20

1

48

4

Invasive pneumococcal disease

41

2

5

48

4

Lead, elevated blood levels

34

0

15

49

3
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Legionellosis

52

0

0

52

0

Leptospirosis

35

0

0

35

17

Listeriosis

52

0

0

52

0

Lyme disease

51

0

0

51

1

Malaria

52

0

0

52

0

Measles

52

0

0

52

0

Meningococcal disease

52

0

0

52

0

Mumps

52

0

0

52

0

Novel influenza A virus
infections
Pertussis

33

9

0

42

10

51

0

0

51

1

Pesticide illness and injury,
acute
Plague

22

4

0

26

26

52

0

0

52

0

Polio, paralytic

51

1

0

52

0

Poliovirus, nonparalytic

22

1

0

23

29

Psittacosis

50

0

0

50

2

Q fever

50

0

0

50

2

Rabies, animal

33

0

0

33

19

Rabies, human

52

0

0

52

0

Rubella

52

0

0

52

0

Rubella, congenital syndrome

44

1

0

45

7

Salmonellosis

52

0

0

52

0

SARS

44

0

0

44

8

Shigellosis

52

0

0

52

0

Silicosis

12

0

3

15

37

Smallpox

50

0

1

51

1

Spotted fever rickettsiosis

12

10

26

48

4

Staphylococcal toxic shock
syndrome
STEC

19

20

0

39

13

49

1

2

52

0

Streptococcal toxic shock
syndrome
Syphilis

23

19

0

42

10

52

0

0

52

0

Tetanus

52

0

0

52

0

Trichinellosis

48

1

0

49

3

Tuberculosis

52

0

0

52

0

Tularemia

52

0

0

52

0

Typhoid fever

49

3

0

52

0

Varicella

39

0

4

43

9

Varicella deaths

10

33

0

43

9

Vibriosis

45

0

0

45

7

Viral hemorrhagic fever

40

1

1

42

10

Vancomycin-intermediate
Staphylococcus aureus

37

2

0

39

13

99

Vancomycin-resistant
Staphylococcus aureus

42

3

0

45

7

Waterborne disease outbreak

22

29

0

51

1

Yellow fever

46

4

0

50

2

Table 3. Nationally notifiable conditions reportable in all jurisdictions
Category
Explicitly reportable
in all jurisdictions

Explicitly reportable
or broadly reportable
in all jurisdictions
Explicitly reportable
or more narrowly
reportable in all
jurisdictions
Explicitly reportable
by any category in all
jurisdictions

Conditions
24 conditions: Anthrax, Botulism, Brucellosis, Cancer, Cholera,
Cryptosporidiosis, Diphtheria, Gonorrhea, HIV Infection,
Legionellosis, Listeriosis, Malaria, Measles, Meningococcal
disease, Mumps, Plague, Rabies, human, Rubella, Salmonellosis,
Shigellosis, Syphilis, Tetanus, Tuberculosis, Tularemia
5 conditions: Congenital syphilis, Hepatitis A (acute), Hepatitis
B (acute), Polio (paralytic), Typhoid fever
3 conditions: Arboviral diseases, Chlamydia
trachomatis infection, Haemophilus influenzae invasive disease

2 conditions: Foodborne disease outbreaks, Shiga toxinproducing Escherichia coli
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Table 4. Percent of conditions required to be reported as part of a broader category than
the NNC
Nationally Notifiable Condition
Varicella deaths
Hepatitis B, perinatal
Hemolytic uremic syndrome, post-diarrheal
Waterborne disease outbreak
Hepatitis C, past or present
Hepatitis B, acute
Staphylococcal TSS
Hepatitis B, chronic
Congenital syphilis
Hepatitis C, acute
Hantavirus pulmonary syndrome
Streptococcal toxic shock syndrome
Pediatric influenza mortality
Foodborne disease outbreak

Percent
77
63
62
57
56
52
51
51
50
49
49
45
44
42

Reportable condition
Varicella
Hepatitis B
Hemolytic uremic syndrome
Disease outbreaks
Hepatitis C
Hepatitis B
Toxic shock syndrome
Hepatitis B
Syphilis
Hepatitis C
Hantavirus
Toxic shock syndrome
Influenza
Disease outbreaks

Table 5. Difference between percent of population covered by required reporting of an
NNC and percent of states requiring the reporting of an NNC (N=52)
NNC
Pesticide Illness and Injury, Acute
Anaplasmosis
Babesiosis
Chancroid
Poliovirus, nonparalytic
Rabies, animal

Percent
Difference
+15
+12
+9
+9
+9
-10
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Table 6. Non-nationally notifiable conditions reportable in a majority of states (N=52)
State Reportable Condition
Unusual disease
AIDS
Group A Streptococcus
Outbreaks
Creutzfeldt-Jakob disease
Yersiniosis

States
52 (100%)
37 (71%)
37 (71%)
37 (71%)
35 (67%)
27 (52%)

Table 7. Required reporting of NNCs removed from the list, 1951-2015 (N=52)
Condition Removed from NNC List

Year Removed

States

Influenza
Pneumonia
Murine typhus fever
Rheumatic fever
Amebiasis
Aseptic meningitis
Encephalitis, post-chickenpox
Encephalitis, post-mumps
Encephalitis, post-other
Encephalitis, primary
Granuloma inguinale
Lymphogranuloma venereum
Hepatitis, non-A, non-B, acute
Group A Streptococcal infections

1951
1951
1994
1994
1995
1995
1995
1995
1995
1995
1995
1995
2002
2010

9 (17%)
0 (0%)
13 (25%)
8 (15%)
15 (29%)
6 (12%)
0 (0%)
0 (0%)
0 (0%)
20 (38%)
14 (27%)
19 (37%)
0 (0%)
37 (71%)
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Table 8. Association of state-specific factors with the number of nationally notifiable
conditions reportable in a state (N=52)
State-specific factor

Health ranking
Public health funding, total
Public health funding, per capita
CDC funding, total
CDC funding, total, per capita
Physicians, per capita
Population
Population density
State area
Vaccination rate
Educational attainment, high school
Educational attainment, bachelors
Educational attainment, advanced
Emerging Infections Program participant

Χ2
0.321
1.282
0.000
1.282
0.000
0.321
1.282
0.321
0.321
1.282
0.321
0.000
0.321
0.721

p-value
0.571
0.258
1.000
0.258
1.000
0.571
0.258
0.571
0.571
0.258
0.571
1.000
0.571
0.396

Table 9. Association between condition-specific factors and the number of states in which
the nationally-notifiable condition was reportable (N=52)
Condition-specific factor

Category A agent
Vaccine-preventable
Notification: immediate, extremely urgent
Notification: immediate, urgent
Notification: standard

Pearson Χ2
1.550
0.036
1.455
0.091
0.887
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p-value
0.213
0.850
0.228
0.763
0.346

Table 10. Conditions added to the NNC between 1992 and 2012
Condition
Escherichia coli O157:H7
Elevated blood lead
Acute pesticide injury or illness
Silicosis
Cyclosporiasis
Ehrlichiosis/Anaplasmosis
Q Fever
Giardiasis
Varicella
Waterborne outbreaks
Vibriosis
Cancer
Streptococcus pneumonia, invasive, < 5 years of age
Streptococcus pneumonia, invasive, all ages
Babesiosis

Year Added
1995
1995
1996
1996
1999
1999
2000
2002
2003
2006
2007
2009
2010
2010
2011

Table 11. Number and percent of NNCs made reportable in states the year of and year
after addition to the NNC list (percent calculated of states requiring reporting) (N=52)
Condition

Babesiosis
Cyclosporiasis
Escherichia coli O157:H7
Ehrlichiosis/Anaplasmosis
Giardiasis
Q Fever
S. pneumonia, invasive, < 5 years of age
S. pneumonia, invasive, all ages
Varicella
Vibriosis
Average

Added in
year 0
24 (73%)
32 (73%)
40 (77%)
30 (68%)
47 (98%)
36 (72%)
27 (59%)
35 (80%)
32 (76%)
36 (82%)
34 (76%)
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Added in
year 1
1 (3%)
2 (5%)
5 (10%)
5 (11%)
0 (0%)
9 (18%)
0 (0%)
5 (11%)
1 (2%)
2 (5%)
3 (7%)

Added after
1 year
8 (24%)
10 (23%)
7 (13%)
9 (20%)
1 (2%)
5 (10%)
19 (41%)
4 (9%)
9 (21%)
6 (14%)
8 (17%)

Table 12. Difference in state blood lead reporting requirements (N=49)
Reporting requirement
Any testing result in all ages
Any testing result in a limited age
group:
• <6 years of age
• <18 years of age
Testing result at or above a
threshold for all ages:
• ≥ 2.3 μg/dl
• > 9 μg/dl
• ≥ 10 μg/dl
Testing result at or above a
threshold in a limited age group:
• <6 years of age, ≥ 10 μg/dl
• <13 years of age, ≥ 5 μg/dl
• <18 years of age, ≥ 10 μg/dl
• <18 years of age, ≥ 25 μg/dl
Different thresholds for a younger
and older age group:
• <6 years, ≥ 5 μg/dl;
≥6 years, ≥ 10 μg/dl
• <16 years, ≥ all results;
≥16 years, ≥ 25 μg/dl
• <16 years, ≥ 10 μg/dl;
≥16 years, ≥ 25 μg/dl
• <18 years, ≥ 5 μg/dl;
≥18 years, ≥ 10 μg/dl
• <18 years, all results;
≥18 years, ≥ 25 μg/dl

States
28 (57%)

4 (8%)
2 (4%)

1 (2%)
1 (2%)
3 (6%)

1 (2%)
1 (2%)
1 (2%)
1 (2%)

1 (2%)
1 (2%)
2 (4%)
1 (2%)
1 (2%)

Table 13. Differences in state pediatric influenza mortality reporting requirements (N=48)
Reporting requirement
Influenza mortality, pediatric (only)
Influenza mortality, all ages
Influenza mortality, under age 65
Influenza mortality, infant
Influenza

States
27 (56%)
11 (23%)
1 (2%)
1 (2%)
8 (17%)
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Table 14. Pediatric influenza mortality additional reporter types (N=48)
Reporting requirement
Only explicitly listed in recommendation
Only not explicitly listed in recommendation
Both explicitly and not explicitly listed in recommendation
No additional reporter types

States
4 (8%)
11 (23%)
32 (67%)
1 (2%)

Table 15. STEC additional reporter types (N=52)
Reporting requirement
Only explicitly listed in recommendation
Only not explicitly listed in recommendation
Both explicitly and not explicitly listed in recommendation
No additional reporter types

States
5 (10%)
11 (21%)
35 (67%)
1 (2%)

Table 16. State tuberculosis reporting requirements (N=52)
Reporting requirement
Active TB only, no pharmacy reporting requirement
Active TB only, includes pharmacy reporting requirement
Active and latent TB, no pharmacy reporting requirement
Active and latent TB, includes pharmacy reporting requirement

States
32 (62%)
12 (23%)
7(13%)
1(2%)

Table 17. Tuberculosis additional reporter types (N=52)
Reporting requirement
Only explicitly listed in recommendation
Only not explicitly listed in recommendation
Both explicitly and not explicitly listed in recommendation
No additional reporter categories
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States
5 (10%)
11 (21%)
35 (67%)
1 (2%)

Appendix C: Nationally Notifiable Condition State Reporting Requirements

Figure 17. State reporting requirements and timeframes for anaplasmosis (N=52)
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Figure 18. State reporting requirements and timeframes for anthrax (N=52)
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Figure 19. State reporting requirements and timeframes for arboviral diseases (N=52)
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Figure 20. State reporting requirements and timeframes for babesiosis (N=52)
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Figure 21. State reporting requirements and timeframes for botulism (N=52)
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Figure 22. State reporting requirements and timeframes for brucellosis (N=52)
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Figure 23. State reporting requirements and timeframes for campylobacteriosis (N=52)
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Figure 24. State reporting requirements and timeframes for cancer (N=52)

114

Figure 25. State reporting requirements and timeframes for carbon monoxide poisoning
(N=52)
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Figure 26. State reporting requirements and timeframes for chancroid (N=52)
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Figure 27. State reporting requirements and timeframes for Chlamydia trachomatis
infection (N=52)
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Figure 28. State reporting requirements and timeframes for cholera (N=52)

118

Figure 29. State reporting requirements and timeframes for coccidioidomycosis (N=52)
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Figure 30. State reporting requirements and timeframes for congenital syphilis (N=52)
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Figure 31. State reporting requirements and timeframes for cryptosporidiosis (N=52)
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Figure 32. State reporting requirements and timeframes for cyclosporiasis (N=52)
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Figure 33. State reporting requirements and timeframes for dengue virus infection (N=52)
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Figure 34. State reporting requirements and timeframes for diphtheria (N=52)
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Figure 35. State reporting requirements and timeframes for ehrlichiosis (N=52)

125

Figure 36. State reporting requirements and timeframes for elevated blood lead levels
(N=52)
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Figure 37. State reporting requirements and timeframes for foodborne disease outbreaks
(N=52)
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Figure 38. State reporting requirements and timeframes for giardiasis (N=52)
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Figure 39. State reporting requirements and timeframes for gonorrhea (N=52)
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Figure 40. State reporting requirements and timeframes for Haemophilus influenza,
invasive disease (N=52)
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Figure 41. State reporting requirements and timeframes for Hansen's disease (N=52)
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Figure 42. State reporting requirements and timeframes for hantavirus infection (N=52)
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Figure 43. State reporting requirements and timeframes for hantavirus pulmonary
syndrome (N=52)
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Figure 44. State reporting requirements and timeframes for hepatitis A, acute (N=52)
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Figure 45. State reporting requirements and timeframes for hepatitis B, acute (N=52)
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Figure 46. State reporting requirements and timeframes for hepatitis B, chronic (N=52)
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Figure 47. State reporting requirements and timeframes for hepatitis B, perinatal (N=52)
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Figure 48. State reporting requirements and timeframes for hepatitis C, acute (N=52)
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Figure 49. State reporting requirements and timeframes for hepatitis C, past or present
(N=52)
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Figure 50. State reporting requirements and timeframes for HIV infection (N=52)
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Figure 51. State reporting requirements and timeframes for hemolytic uremic syndrome,
post-diarrheal (N=52)
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Figure 52. State reporting requirements and timeframes for influenza pediatric mortality
(N=52)
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Figure 53. State reporting requirements and timeframes for invasive pneumococcal disease
(N=52)
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Figure 54. State reporting requirements and timeframes for legionellosis (N=52)
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Figure 55. State reporting requirements and timeframes for leptospirosis (N=52)
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Figure 56. State reporting requirements and timeframes for listeriosis (N=52)
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Figure 57. State reporting requirements and timeframes for lyme disease (N=52)

147

Figure 58. State reporting requirements and timeframes for malaria (N=52)
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Figure 59. State reporting requirements and timeframes for measles (N=52)
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Figure 60. State reporting requirements and timeframes for meningococcal disease (N=52)
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Figure 61. State reporting requirements and timeframes for mumps (N=52)
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Figure 62. State reporting requirements and timeframes for novel influenza A virus
infections (N=52)
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Figure 63. State reporting requirements and timeframes for pertussis (N=52)

153

Figure 64. State reporting requirements and timeframes for pesticide injury and illness,
acute (N=52)
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Figure 65. State reporting requirements and timeframes for plague (N=52)
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Figure 66. State reporting requirements and timeframes for polio, paralytic (N=52)
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Figure 67. State reporting requirements and timeframes for poliovirus, non-paralytic
(N=52)
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Figure 68. State reporting requirements and timeframes for psittacosis (ornithosis) (N=52)
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Figure 69. State reporting requirements and timeframes for Q fever (N=52)
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Figure 70. State reporting requirements and timeframes for rabies, animal (N=52)
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Figure 71. State reporting requirements and timeframes for rabies, human (N=52)
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Figure 72. State reporting requirements and timeframes for rubella, congenital syndrome
(N=52)
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Figure 73. State reporting requirements and timeframes for rubella (N=52)
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Figure 74. State reporting requirements and timeframes for salmonellosis (N=52)
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Figure 75. State reporting requirements and timeframes for severe acute respiratory
syndrome (SARS) (N=52)
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Figure 76. State reporting requirements and timeframes for shigellosis (N=52)
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Figure 77. State reporting requirements and timeframes for silicosis (N=52)
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Figure 78. State reporting requirements and timeframes for smallpox (N=52)
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Figure 79. State reporting requirements and timeframes for spotted fever rickettsiosis
(N=52)
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Figure 80. State reporting requirements and timeframes for staphyloccal toxic shock
syndrome (N=52)
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Figure 81. State reporting requirements and timeframes for Shiga-toxin producing
Escherichia coli (N=52)
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Figure 82. State reporting requirements and timeframes for streptococcal toxic shock
syndrome (N=52)
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Figure 83. State reporting requirements and timeframes for syphilis (N=52)
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Figure 84. State reporting requirements and timeframes for tetanus (N=52)
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Figure 85. State reporting requirements and timeframes for trichinellosis (N=52)
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Figure 86. State reporting requirements and timeframes for tuberculosis (N=52)
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Figure 87. State reporting requirements and timeframes for tularemia (N=52)
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Figure 88. State reporting requirements and timeframes for typhoid fever (N=52)
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Figure 89. State reporting requirements and timeframes for varicella deaths (N=52)
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Figure 90. State reporting requirements and timeframes for varicella (N=52)
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Figure 91. State reporting requirements and timeframes for vibriosis (N=52)
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Figure 92. State reporting requirements and timeframes for viral hemorrhagic fever
(N=52)
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Figure 93. State reporting requirements and timeframes for vancomycin-intermediate
Staphylococcus aureus (VISA) (N=52)
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Figure 94. State reporting requirements and timeframes for vancomycin-resistant
Staphylococcus aureus (VRSA) (N=52)
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Figure 95. State reporting requirements and timeframes for waterborne disease outbreaks
(N=52)
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Figure 96. State reporting requirements and timeframes for yellow fever (N=52)
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